Abstract is: Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occur in both nostrils in those who are affected. Complications may include sinusitis and broadening of the nose. The exact cause is unclear. They may be related to chronic inflammation of the lining of the sinuses. They occur more commonly among people who have allergies, cystic fibrosis, aspirin sensitivity, or certain infections. The polyp itself represents an overgrowth of the mucous membranes. Diagnosis may be accomplished by looking up the nose. A CT scan may be used to determine the number of polyps and help plan surgery. Treatment is typically with steroids, often in the form of a nasal spray. If this is not effective, surgery may be considered. The condition often recurs following surgery; thus, continued use of a steroid nasal spray is often recommended. Antihistamines may help with symptoms but do not change the underlying disease. Antibiotics are not required for treatment unless an infection occurs. About 4% of people currently have nasal polyps while up to 40% of people develop them at some point in their life. They most often occur after the age of 20 and are more frequent in males than females. Nasal polyps have been described since the time of the Ancient Egyptians.
| head and neck disease | Q55789477 |
| polyp | Q657665 |
| polyposis | Q2103081 |
| nose disease | Q10267828 |
| nasal cavity neoplasm | Q18558103 |
| P2581 | BabelNet ID | 03570489n |
| 03570489n | ||
| P673 | eMedicine ID | 861456 |
| P10565 | Encyclopedia of China (Third Edition) ID | 457385 |
| P1417 | Encyclopædia Britannica Online ID | science/nasal-polyp |
| P2888 | exact match | http://purl.obolibrary.org/obo/HP_0100582 |
| P11956 | Experimental Factor Ontology ID | 1000391 |
| P646 | Freebase ID | /m/034hsj |
| P3841 | Human Phenotype Ontology ID | HP:0100582 |
| P494 | ICD-10 ID | J33 |
| P7807 | ICD-11 ID (Foundation) | 137754914 |
| P7329 | ICD-11 ID (MMS) | CA0J |
| P493 | ICD-9 ID | 471 |
| P1692 | ICD-9-CM | 471.0 |
| 471.9 | ||
| P667 | ICPC 2 ID | R99 |
| P3827 | JSTOR topic ID (archived) | nasal-polyps |
| P3201 | Medical Dictionary for Regulatory Activities ID | 10028754 |
| 10028754 | ||
| P604 | MedlinePlus ID | 001641 |
| 001641 | ||
| P486 | MeSH descriptor ID | D009298 |
| P672 | MeSH tree code | C08.460.572 |
| C09.603.557 | ||
| C23.300.825.557 | ||
| P6366 | Microsoft Academic ID | 2908611571 |
| P5270 | Mondo ID | MONDO_0006314 |
| P8189 | National Library of Israel J9U ID | 987007558250905171 |
| P1748 | NCI Thesaurus ID | C3256 |
| P7995 | NHS Health A to Z ID | nasal-polyps |
| P691 | NL CR AUT ID | ph210241 |
| P10283 | OpenAlex ID | C2781390199 |
| P4233 | PatientsLikeMe condition ID | nasal-sinus-polyps |
| P2892 | UMLS CUI | C0027430 |
| P11143 | WikiProjectMed ID | Nasal polyp |
| P2176 | drug or therapy used for treatment | mometasone | Q28208887 |
| P1995 | health specialty | otolaryngology | Q189553 |
| pulmonology | Q203337 | ||
| P443 | pronunciation audio | Audio pronunciation file from the Lingua Libre  project.License: CC0 Artists:
This work is copyrighted. |
| Q113915092 | Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab) |
| Q113932563 | BIOlogics in Severe Nasal POlyposis SurvEy |
| Q113891644 | Comparison of Methylprednisolone or Methotrexate in the Maintenance Treatment of Nasal Polyposis |
| Q113919217 | Compassionate Use of Dupilumab |
| Q113932048 | Development of a Severity Assessment Score for Nasosinus Polyposis (PSI Score) |
| Q113945019 | Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction? |
| Q113943880 | Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis |
| Q113893663 | Dupilumab for Prevention of Recurrence of CRSwNP After ESS |
| Q113929983 | Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52) |
| Q113890517 | Effect of Vitamin d Deficiency in Chronic Rhinosinusitis With Nasal Polyposis |
| Q113942632 | Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps |
| Q113943216 | Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2) |
| Q113895394 | Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS) |
| Q113910032 | Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis |
| Q113921369 | Novel Inflammatory Markers in Different Phenotypes of Severe Asthma |
| Q113917704 | Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis |
| Q113911604 | Preclinical Studies of Omalizumab in Chronic Rhinosinusitis With Nasal Polyposis |
| Q113924450 | RANS. Study in Patients With Severe Eosinophilic Asthma and Nasal Polyps. |
| Q113932379 | Role of Doxycycline in Chronic Rhinosinusitis With Nasal Polyps |
| Q113944854 | Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis |
| Q113910075 | The Effect of Modified Radical Endoscopic Sinus Surgery on Eosinopilic Chronic Rhinosinusitus With Nasal Polyps |
| Q113894466 | Tissue Immune Interaction in Nasal Polyposis |
| Q113928037 | Treatment With Mepolizumab on Patients With Severe Refractory Eosinophilic Asthma With or Without CRSwNP. |
| Q54811449 | CFNPE9o- |
| Q54837694 | GM02801 |
| Q112930202 | NP2 |
| Q112930205 | NP2/K4DT |
| Q112930209 | NP23(CF) |
| Q112930211 | NP24(CF) |
| Q112930213 | NP3 |
| Q112930214 | NP3/T |
| Q112930215 | NP34 |
| Q90776038 | 1,8-cineol inhibits the Wnt/β-catenin signaling pathway through GSK-3 dephosphorylation in nasal polyps of chronic rhinosinusitis patients |
| Q93568423 | 131 Expression of Chemokine Receptors CCR1, CCR3, CCR4, CCR5, CCR8 and CXCR3 in Human Nasal Polyps (NP); Comparison With NP From Allergic Patients With Aspirin Intolerance |
| Q91846868 | 15-Lipoxygenase 1 in nasal polyps promotes CCL26/eotaxin 3 expression through extracellular signal-regulated kinase activation |
| Q93568002 | 228 PCR Analysis of Microorganisms in Chronic Rhinosinusitis with Nasal Polyps |
| Q94583981 | 5-HT7 receptorsare over-expressed in patients with nasal polyps |
| Q89091731 | 5-Oxo-ETE from Nasal Epithelial Cells Upregulates Eosinophil Cation Protein by Eosinophils in Nasal Polyps in vitro |
| Q91987597 | A 10-Year Follow-Up of a Randomized Prospective Study of 2 Treatments for Chronic Rhinosinusitis Without Nasal Polyps and Investigation of the Impact of Gastroeosophageal Reflux Disease in the Resistance to Treatment |
| Q91691778 | A Case Report of Aggressive Chronic Rhinosinusitis with Nasal Polyps Mimicking Sinonasal Malignancy |
| Q41294394 | A HISTOLOGICAL STUDY OF HYALINE DEPOSITS IN LARYNGEAL, AURAL, AND NASAL POLYPS AND THEIR DIFFERENTIATION FROM AMYLOID. |
| Q42026077 | A Recently Established Murine Model of Nasal Polyps Demonstrates Activation of B Cells, as Occurs in Human Nasal Polyps. |
| Q62520482 | A Short Course of Oral Prednisone Followed by Intranasal Budesonide Is an Effective Treatment of Severe Nasal Polyps |
| Q91799181 | A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps |
| Q77474680 | A case of metastatic nasopharyngeal carcinoma in benign nasal polyps |
| Q92593786 | A classification of chronic rhinosinusitis with nasal polyps based on structured histopathology |
| Q32091964 | A clinico-morphological rationale for the use of heparin in nasal polyps occurring with rhinosinusitis in children |
| Q55279400 | A disintegrin and metalloprotease 10-containing exosomes derived from nasal polyps promote angiogenesis and vascular permeability. |
| Q47105919 | A family-based genome-wide association study of chronic rhinosinusitis with nasal polyps implicates several genes in the disease pathogenesis |
| Q92045996 | A genetic variant near TSLP is associated with chronic rhinosinusitis with nasal polyps and aspirin-exacerbated respiratory disease in Japanese populations |
| Q46027880 | A historical cohort study of eosinophilic inflammation in chronic rhinosinusitis with nasal polyps in Okayama, Japan. |
| Q91045739 | A loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis |
| Q58127257 | A mometasone-eluting sinus implant (Sinuva) for nasal polyps |
| Q90205198 | A new treatment for chronic rhinosinusitis with nasal polyps |
| Q74210034 | A prospective treatment trial of nasal polyps in adults with cystic fibrosis |
| Q58306728 | A relationship between mast cells and α-smooth muscle actin-positive cells in the nasal polyps of chronic rhinosinusitis |
| Q91879313 | A retrospective study of changes of histopathology of nasal polyps in adult Chinese in central China |
| Q90864131 | A structured histopathology-based analysis of surgical outcomes in chronic rhinosinusitis with and without nasal polyps |
| Q99574012 | A substantial neutrophilic inflammation as regular part of severe type 2 chronic rhinosinusitis with nasal polyps |
| Q71682412 | A survey to determine the extent of previous symptoms and surgery on patients presenting with nasal polyps |
| Q95517666 | ANTIPROLIFERATIVE AND CYTOTOXIC EFFECT OF SELECTED VITAMIN D ANALOGS ON NASAL POLYPS FIBROBLASTS AND OTHER CELLS WITH HIGHER PROLIFERATIVE POTENTIAL |
| Q59127194 | Aberrant localization of FOXJ1 correlates with the disease severity and comorbidities in patients with nasal polyps |
| Q88636802 | Accumulation of CD69+ tissue‑resident memory T cells in the nasal polyps of patients with chronic rhinosinusitis |
| Q72055172 | Accumulation of interferon gamma-producing TH1 helper T cells in nasal polyps |
| Q38441352 | Activated eosinophils in nasal polyps: a comparison of asthmatic and non-asthmatic patients |
| Q92938251 | Activated pyrin domain containing 3 (NLRP3) inflammasome in neutrophilic chronic rhinosinusitis with nasal polyps (CRSwNP) |
| Q100456608 | Add-on effect of clarithromycin to oral steroids as post- operative therapy for chronic rhinosinusitis with nasal polyps: a randomised controlled trial |
| Q67794975 | Adenylate cyclase activity in human nasal polyps under conditions of stimulation of serotonin biosynthesis (in vitro) |
| Q28194664 | Adhesion molecules and their ligands in nasal polyps of aspirin-hypersensitive patients |
| Q78112001 | Advances in the medical treatment of nasal polyps |
| Q47776288 | Aeroallergen hypersensitivity: comparing patients with nasal polyps to those with allergic rhinitis. |
| Q36549192 | Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling |
| Q50060021 | Age-related prevalence of chronic rhinosinusitis and nasal polyps and their relationships with asthma onset. |
| Q91992969 | Agonist of PPAR-γ Reduced Epithelial-Mesenchymal Transition in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps via Inhibition of High Mobility Group Box1 |
| Q80466220 | Agreement rate of skin prick test with tissue eosinophil count in patients with nasal polyps |
| Q35680199 | Airway Inflammation in Chronic Rhinosinusitis with Nasal Polyps and Asthma: The United Airways Concept Further Supported |
| Q71492234 | Airway reactivity of nose and bronchi in patients with nasal polyps |
| Q92283804 | Akt and estrogen receptor expression in nasal polyps |
| Q41668574 | Albumin and immunoglobulin levels in nasal secretions of patients with nasal polyps treated with endoscopic sinus surgery and topical corticosteroids |
| Q73320875 | All nasal polyps need histological examination: an audit-based appraisal of clinical practice |
| Q73688601 | All nasal polyps need histological examination: an audit-based appraisal of clinical practice |
| Q67324155 | Allergic management of nasal polyps |
| Q73427941 | Allergic management of nasal polyps |
| Q28184591 | Allergic nasal polyps under scanning electron microscope |
| Q53793554 | Allergic profiles in unilateral nasal polyps of bilateral chronic rhinosinusitis. |
| Q74175528 | Allergic rhinitis and nasal polyps |
| Q86690320 | Allergogenic profile in patients with different subtypes of chronic rhinosinusitis with nasal polyps |
| Q68083327 | Allergy is not a significant cause of nasal polyps |
| Q68200881 | Allergy is not a significant cause of nasal polyps |
| Q42542926 | Allergy: nasal polyps and allergy. |
| Q94646881 | Altered Mitochondrial Functions and Morphologies in Epithelial Cells Are Associated With Pathogenesis of Chronic Rhinosinusitis With Nasal Polyps |
| Q60516803 | Altered Th17/Treg Ratio in Nasal Polyps With Distinct Cytokine Profile |
| Q37207077 | Altered Th17/Treg Ratio in Nasal Polyps With Distinct Cytokine Profile: Association With Patterns of Inflammation and Mucosal Remodeling |
| Q50271674 | Altered expression and signalling of EP2 receptor in nasal polyps of AERD patients: role in inflammation and remodelling |
| Q82844966 | Altered expression profile of superoxide dismutase isoforms in nasal polyps from nonallergic patients |
| Q36853883 | Ambulatory removal of nasal polyps using laser methods? |
| Q46745316 | Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: a randomized, placebo-controlled, double-blind study |
| Q80241717 | Amphotericin B nasal spray has no effect on nasal polyps |
| Q91670920 | An Integrated Analysis of Radial Spoke Head and Outer Dynein Arm Protein Defects and Ciliogenesis Abnormality in Nasal Polyps |
| Q98897936 | An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma |
| Q98565741 | Analysis of expression profiling data suggests explanation for difficulties in finding biomarkers for nasal polyps |
| Q70811792 | Analysis of glycoproteins from nasal polyps and papillomas by affinity chromatography |
| Q80988310 | Analysis of most common CFTR mutations in patients affected by nasal polyps |
| Q67833371 | Analysis of the cellular infiltrate and epithelial class I and II molecular expression in edematous type nasal polyps |
| Q91183366 | Analysis of the impact of bronchial asthma and hypersensitivity to aspirin on the clinical course of chronic sinusitis with nasal polyps |
| Q70955323 | Anaphylaxis in patient with nasal polyps is likely due to aspirin sensitivity |
| Q87825103 | Andrographolide suppresses IL-6/Stat3 signaling in peripheral blood mononuclear cells from patients with chronic rhinosinusitis with nasal polyps |
| Q33855711 | Angiectatic nasal polyps that clinically simulate a malignant process: report of 2 cases and review of the literature |
| Q51747079 | Angiogenesis in chronic rhinosinusitis with nasal polyps and in antrochoanal polyps |
| Q46428686 | Antibiofilm effects of topical corticosteroids and intranasal saline in patients with chronic rhinosinusitis with nasal polyps depend on bacterial species and their biofilm-forming capacity |
| Q90414755 | Antibiotics, steroids, and combination therapy in chronic rhinosinusitis without nasal polyps in adults |
| Q82816106 | Antigen selection in IgE antibodies from individuals with chronic rhinosinusitis with nasal polyps |
| Q95787971 | Antimicrobial peptides in nasal secretion and mucosa with respect to Staphylococcus aureus colonization in chronic rhinosinusitis with nasal polyps |
| Q53161698 | Apoptosis in eosinophilic nasal polyps treated in vitro with mitomycin C. |
| Q93008106 | Application of Clinical Scores in the Differential Diagnosis of Chronic Rhinosinusitis With Nasal Polyps in a Chinese Population |
| Q72553971 | Apropos of mucous nasal polyps |
| Q58264220 | Arachidonic Acid Metabolites in Human Nasal Polyps |
| Q71087972 | Arachidonic acid metabolism in nasal polyps and allergic inflammation |
| Q70619929 | Are nasal polyps an allergic phenomenon? |
| Q98213225 | Are patients with chronic rhinosinusitis with nasal polyps at a decreased risk of COVID-19 infection? |
| Q50709817 | Asian nasal polyps: a separate entity? |
| Q42456593 | Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)? |
| Q28195777 | Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild topic asthma, and normal controls |
| Q70604659 | Aspirin shock associated with asthma and nasal polyps |
| Q28192015 | Aspirin treatment of patients with aspirin intolerance, asthma, and nasal polyps |
| Q64052221 | Aspirin-induced asthma and nasal polyps |
| Q67596561 | Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps |
| Q100386688 | Assessing effects of modification of middle meatal silastic splint after endoscopic sinus surgery for nasal polyps: A randomized controlled study |
| Q48345724 | Assessment of laryngopharyngeal reflux and the shape of the Eustachian tube should be considered in chronic rhinosinusitis with nasal polyps and chronic otitis media. |
| Q61970320 | Association between Group 2 Innate Lymphoid Cells enrichment, nasal polyps and allergy in Chronic Rhinosinusitis |
| Q91453272 | Association between methylation in nasal epithelial TSLP gene and chronic rhinosinusitis with nasal polyps |
| Q96813683 | Association between the NOS2 pentanucleotide repeat polymorphism and risk of postoperative recurrence of chronic rhinosinusitis with nasal polyps in a Japanese population |
| Q96762420 | Association between the sinus microbiota with eosinophilic inflammation and prognosis in chronic rhinosinusitis with nasal polyps |
| Q54216253 | Association of IL1β and IL4 gene polymorphisms with nasal polyps in a Polish population. |
| Q98190066 | Association of MUC2, MUC5AC and MUC5B genes with the recurrence of nasal polyps |
| Q45802412 | Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers. |
| Q36081333 | Association of the -14C/G MET and the -765G/C COX-2 gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population |
| Q54333829 | Association of the -33C/G OSF-2 and the 140A/G LF gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population. |
| Q90775075 | Associations between the Quality of Life and Nasal Polyp Size in Patients Suffering from Chronic Rhinosinusitis without Nasal Polyps, with Nasal Polyps or Aspirin-Exacerbated Respiratory Disease |
| Q68767963 | Asthma, aspirin intolerance and nasal polyps |
| Q79312044 | Asymptomatic IgE mediated food hypersensitivity in patients with nasal polyps |
| Q42625032 | Atypical stromal cells in inflammatory nasal polyps: immunohistochemical and ultrastructural analysis in defining histogenesis |
| Q89358244 | Authors' Reply: Prognosis and risk in considering extensive vs functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps and asthma |
| Q50936281 | Autophagy is deficient and inversely correlated with COX-2 expression in nasal polyps: a novel insight into the inflammation mechanism. |
| Q39069254 | Autophagy is deficient in nasal polyps: implications for the pathogenesis of the disease |
| Q73318020 | Bacterial flora as a potential etiopathogenic factor for nasal polyps |
| Q74313506 | Basic fibroblast growth factor in nasal polyps immunohistochemical and quantitative findings |
| Q40126031 | Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity |
| Q67319959 | Benign Nasal Polyps Causing Bone Destruction in the Nasal Cavity and Paranasal Sinuses |
| Q53412154 | Bilateral nasal polyps originating from the nasal septum: a case report. |
| Q76110719 | Biochemical aspects of nasal polyps |
| Q83149917 | Biofilm in chronic sinusitis with nasal polyps: pilot study |
| Q33400026 | Biofilm in nasal polyps |
| Q67666105 | Biogenic amines in nasal mucosa and nasal polyps |
| Q90761262 | Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps |
| Q91925560 | Biologic Therapy in a Patient with Asthma and Nasal Polyps |
| Q90131044 | Biologics for chronic rhinosinusitis with nasal polyps |
| Q92890397 | Biologics for the treatment of chronic rhinosinusitis with nasal polyps - state of the art |
| Q102064076 | Biology and Function of Eosinophils in Chronic Rhinosinusitis With or Without Nasal Polyps |
| Q57787275 | Biomarkers in Chronic Rhinosinusitis with Nasal Polyps |
| Q104568976 | Biotherapy and treatment of adult primary chronic rhinosinusitis with nasal polyps: Cellular and molecular bases |
| Q98776843 | Blood Eosinophilic and Basophilic Trends in Recurring and Non-Recurring Eosinophilic Rhinosinusitis With Nasal Polyps |
| Q70061826 | Blood flow in nasal polyps |
| Q91580939 | Broad IgG repertoire in patients with chronic rhinosinusitis with nasal polyps regulates proinflammatory IgE responses |
| Q39566764 | Bronchial asthma, nasal polyps, and aspirin sensitivity: Samter's syndrome |
| Q41221259 | Bronchial reactivity in patients with nasal polyps |
| Q92185369 | Budget Impact of a Steroid-Eluting Sinus Implant Versus Sinus Surgery for Adult Chronic Sinusitis Patients with Nasal Polyps |
| Q99566301 | Burden of Nasal Polyps in the United States |
| Q93138913 | CD3+CD4-CD8- mucosal T cells are associated with uncontrolled chronic rhinosinusitis with nasal polyps |
| Q45873513 | CFTR transgene expression in primary DeltaF508 epithelial cell cultures from human nasal polyps following gene transfer with cationic phosphonolipids |
| Q94952992 | COVID-19 infection in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab |
| Q84581438 | COX/PGE(2) axis critically regulates effects of LPS on eosinophilia-associated cytokine production in nasal polyps |
| Q69726066 | CT appearance distinguishing benign nasal polyps from malignancies |
| Q39551281 | Categorizing nasal polyps by severity and controller therapy. |
| Q84211810 | Cathepsin D activity in nasal polyps |
| Q52962714 | Cellular proliferation and angiogenesis in nasal polyps of young adult and geriatric patients. |
| Q90632547 | Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps |
| Q97678225 | Central compartment atopic disease: the missing link in the allergy and chronic rhinosinusitis with nasal polyps saga |
| Q57223831 | Changes in histological features of nasal polyps in a Korean population over a 17-year period |
| Q93382378 | Changes in the clinical and histological characteristics of Chinese chronic rhinosinusitis with nasal polyps over 11 years |
| Q46657890 | Changes of glucocorticoid receptor expression in the nasal polyps of patients with chronic sinusitis following treatment with glucocorticoid. |
| Q67687010 | Characterization and Quantification of Cellular Infiltrates in Nasal Mucosa of Patients with Grass Pollen Allergy, Non-Allergic Patients with Nasal Polyps and Controls |
| Q74575999 | Characterization of the eosinophil chemokine RANTES in nasal polyps |
| Q90015644 | Charcot-Leyden crystal concentration in nasal secretions predicts clinical response to glucocorticoids in patients with chronic rhinosinusitis with nasal polyps |
| Q84462877 | Chitinolytic activity in nasal polyps |
| Q71102296 | Chromosome changes in nonneoplastic tissue. Numerical and structural abnormalities in nasal polyps with atypical stromal cells |
| Q100496742 | Chronic Rhinosinusitis With Nasal Polyps In Patients With Aspirin Sensitivity-Mycophenolate Mofetil as an Effective Steroid-Sparing Agent |
| Q100682803 | Chronic Rhinosinusitis With Nasal Polyps and Asthma |
| Q91585672 | Chronic Rhinosinusitis with Nasal Polyps |
| Q93119602 | Chronic Rhinosinusitis with Nasal Polyps in Older Adults: Clinical Presentation, Pathophysiology, and Comorbidity |
| Q104486779 | Chronic Rhinosinusitis with Nasal Polyps: Targeting IgE with Anti-IgE Omalizumab Therapy |
| Q61817011 | Chronic Rhinosinusitis without Nasal Polyps in Asian Patients Shows Mixed Inflammatory Patterns and Neutrophil-Related Disease Severity |
| Q41738271 | Chronic obstructive pulmonary disease predicts chronic rhinosinusitis without nasal polyps: A population-based study |
| Q53608369 | Chronic panrhinosinusitis without nasal polyps: long-term outcome after functional endoscopic sinus surgery. |
| Q37265116 | Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life |
| Q36541798 | Chronic rhinosinusitis and recurrent nasal polyps in two children with IgG subclass deficiency and review of the literature. |
| Q91634991 | Chronic rhinosinusitis precipitated by tumor necrosis factor alpha inhibitors is the phenotype of chronic rhinosinusitis without nasal polyps |
| Q51786931 | Chronic rhinosinusitis with and without nasal polyps is associated with decreased expression of glucocorticoid-induced leucine zipper. |
| Q49137965 | Chronic rhinosinusitis with and without nasal polyps: what is the difference? |
| Q44688659 | Chronic rhinosinusitis with nasal polyps (CRSwNPs) and allergic rhinitis (AR). |
| Q88186652 | Chronic rhinosinusitis with nasal polyps and without nasal polyps is associated with increased expression of lysophosphatidic acid-related molecules |
| Q91592057 | Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry |
| Q46028225 | Chronic rhinosinusitis with nasal polyps in the elderly. |
| Q47247118 | Chronic rhinosinusitis with nasal polyps in the elderly: Assessing current evidence |
| Q40497210 | Chronic rhinosinusitis with nasal polyps is associated with chronic otitis media in the elderly. |
| Q81375731 | Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor |
| Q37090556 | Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression |
| Q54203586 | Chronic rhinosinusitis with nasal polyps is characterized by dysbacteriosis of the nasal microbiota. |
| Q101241325 | Chronic rhinosinusitis with nasal polyps management in the age of biologics |
| Q53178446 | Chronic rhinosinusitis with nasal polyps: a proteomic analysis. |
| Q37965065 | Chronic rhinosinusitis with nasal polyps: elevated serum immunoglobulin E is associated with Staphylococcus aureus on culture |
| Q58110821 | Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies |
| Q101223808 | Chronic rhinosinusitis with nasal polyps: mechanistic insights from targeting IL-4 and IL-13 via IL-4Rα inhibition with dupilumab |
| Q87683691 | Chronic rhinosinusitis without nasal polyps is associated with increased expression of trefoil factor family peptides |
| Q81113887 | Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation |
| Q50426488 | Cigarette smoke promotes eosinophilic inflammation, airway remodeling, and nasal polyps in a murine polyp model. |
| Q64941717 | Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial. |
| Q39175214 | Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease |
| Q58118508 | Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in an Academic Setting |
| Q47724019 | Clinical Phenotypes of Nasal Polyps and Comorbid Asthma Based on Cluster Analysis of Disease History. |
| Q90111680 | Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics. A National Institute of Allergy and Infectious Diseases Workshop |
| Q94925479 | Clinical and Pathological Features of Angiomatous Nasal Polyps: A Report of Four Cases and Review of Literature |
| Q84186203 | Clinical and histopathologic features of biofilm-associated chronic rhinosinusitis with nasal polyps in Chinese patients |
| Q74519243 | Clinical and histopathological correlation of nasal polyps: are there any surprises? |
| Q41970127 | Clinical aspects and distribution of immunologically active cells in the nasal mucosa of patients with nasal polyps after endoscopic sinus surgery and treatment with topical corticosteroids |
| Q72418809 | Clinical course of patients with primary nasal polyps |
| Q28194621 | Clinical factors influencing the eosinophil infiltration of nasal polyps |
| Q70592071 | Clinical profile and recurrence of nasal polyps |
| Q28167362 | Clinical relevance of nasal polyps in individuals recruited from a general population-based study |
| Q96644955 | Clinical-Cytological-Grading and phenotyping in patients with chronic rhinosinusitis with nasal polyps: the relevance in clinical practice |
| Q70686498 | Clinico-anatomical parallels in patients with primary and recurrent nasal polyps |
| Q80146412 | Co-expression of the TGF-beta1 and TGF- beta2 isoforms in nasal polyps and in healthy mucosa |
| Q92566734 | Co-occurrence of Nasal Polyps and Neoplasms of the Canine Nasal Cavity |
| Q90557070 | Cold-inducible RNA-binding protein contributes to tissue remodeling in chronic rhinosinusitis with nasal polyps |
| Q100502171 | Comment on: Predictive and Diagnostic Value of Nasal Nitric Oxide in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps |
| Q89951750 | Common fibrin deposition and tissue plasminogen activator downregulation in nasal polyps with distinct inflammatory endotypes |
| Q86753215 | Comorbidity has no impact on eosinophil inflammation in the upper airways or on severity of the sinonasal disease in patients with nasal polyps |
| Q58307339 | Comparative Assessment of Cell Proliferation and Accumulation of Extracellular Matrix in Nasal Polyps |
| Q42107209 | Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps |
| Q92579018 | Comparison of Corticosteroids by 3 Approaches to the Treatment of Chronic Rhinosinusitis With Nasal Polyps |
| Q70322025 | Comparison of arachidonic acid metabolism in nasal polyps and eosinophils |
| Q58284305 | Comparison of bacterial examinations between eosinophilic and neutrophilic chronic rhinosinusitis with nasal polyps |
| Q83075238 | Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults |
| Q60045965 | Comparison of four staining methods for detecting eosinophils in nasal polyps |
| Q82285108 | Comparison of montelukast and mometasone furoate in the prevention of recurrent nasal polyps |
| Q91195891 | Comparison of subjective and objective assessment of glucocorticoid response in nasal polyps: a preliminary study |
| Q64102598 | Computed Tomography Findings in Patients with Samter's Triad: An Observational Study |
| Q73512731 | Concentration of s-ICAM-1 in nasal polyps tissue |
| Q70802761 | Concomitant nasal polyps, bronchial asthma, and aspirin sensitivity: report of three cases |
| Q92890404 | Concordant systemic and local eosinophilia relates to poorer disease control in patients with nasal polyps |
| Q31127645 | Connectivity can be used to identify key genes in DNA microarray data: a study based on gene expression in nasal polyps before and after treatment with glucocorticoids. |
| Q28168107 | Contemporary management of nasal polyps |
| Q92423596 | Contribution of Epithelial Cell Dysfunction to the Pathogenesis of Chronic Rhinosinusitis with Nasal Polyps |
| Q67913642 | Conversion of leukotriene A4 to lipoxins by human nasal polyps and bronchial tissue |
| Q42057029 | Correlation analysis of prognostic and pathological features of patients with chronic sinusitis and nasal polyps following endoscopic surgery |
| Q46363432 | Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma |
| Q99407050 | Correlation of Bromodomain Protein BRD4 Expression With Epithelial-Mesenchymal Transition and Disease Severity in Chronic Rhinosinusitis With Nasal Polyps |
| Q50456188 | Correlation of basophil infiltration in nasal polyps with the severity of chronic rhinosinusitis. |
| Q34541847 | Correlation of computed tomography with pathological features in angiomatous nasal polyps |
| Q92774131 | Correlation of tissue eosinophil count and chemosensory functions in patients with chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery |
| Q102069195 | Corrigendum: Correlation of Bromodomain Protein BRD4 Expression With Epithelial-Mesenchymal Transition and Disease Severity in Chronic Rhinosinusitis With Nasal Polyps |
| Q52657565 | Cortactin expression in nasal polyps of Aspirin-Exacerbated Respiratory Disease (AERD) patients. |
| Q55070132 | Corticosteroid regulates epithelial occludin expression in nasal polyps through a MKP-1-dependent pathway. |
| Q91534932 | Cost Utility Analysis of Dupilumab Versus Endoscopic Sinus Surgery for Chronic Rhinosinusitis With Nasal Polyps |
| Q91346462 | Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps |
| Q91608500 | Cross-talk between TH2 and TH17 pathways in patients with chronic rhinosinusitis with nasal polyps |
| Q74339346 | Culture of human nasal epithelial cells from nasal polyps on collagen matrix |
| Q58192637 | Cultured nasal polyps from nonatopic and atopic patients release RANTES spontaneously and after stimulation with phytohemagglutinin |
| Q72835465 | Current clinico-therapeutic findings in nasal polyps |
| Q38064137 | Current view on nasal polyps management in Samter's triad patients |
| Q62520492 | Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps |
| Q43686709 | Cyclooxygenase 2 and lipoxin A₄ in nasal polyps in cystic fibrosis |
| Q74052337 | Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps |
| Q77950275 | Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics |
| Q60147713 | Cysteinyl Leukotriene 1 Receptor Expression in Nasal Polyps |
| Q91062416 | Cysteinyl leukotriene 1 receptor expression in nasal polyps |
| Q42477756 | Cytokeratin expression in human respiratory epithelium of nasal polyps and turbinates |
| Q70786300 | Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps |
| Q77146852 | Cytokine gene expression in nasal polyps |
| Q83929772 | Cytokines profile in cystic fibrosis patients with nasal polyps |
| Q40966276 | DEXAMETHASONE NASAL AEROSOL IN NASAL POLYPS AND HYPERTROPHIC ALLERGIC RHINITIS: A CLINICAL AND CONTROLLED EVALUATION |
| Q89371957 | DNA Methylation of Proximal PLAT Promoter in Chronic Rhinosinusitis With Nasal Polyps |
| Q92832480 | Decrease in number of mast cells in resected nasal polyps as an indicator for postoperative recurrence of chronic rhinosinusitis |
| Q46073257 | Decreased PLUNC expression in nasal polyps is associated with multibacterial colonization in chronic rhinosinusitis patients |
| Q28193060 | Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity |
| Q33213301 | Decreased connexin 43 expression correlated with eosinophil infiltration in nasal polyps |
| Q92870357 | Decreased expression of type I (IFN-β) and type III (IFN-λ) interferons and interferon-stimulated genes in patients with chronic rhinosinusitis with and without nasal polyps |
| Q73147021 | Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps |
| Q104503987 | Defective STING expression potentiates IL-13 signaling in epithelial cells in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q57036848 | Deficiency in interleukin-10 production by M2 macrophages in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q104109014 | Deficit in Adipose Differentiation in Mesenchymal Stem Cells Derived from Chronic Rhinosinusitis Nasal Polyps Compared to Nasal Mucosal Tissue |
| Q67667173 | Demonstration of clusters in nasal polyps a light and electron microscopic investigation (author's transl) |
| Q35782188 | Detection of Epstein-Barr virus-infected mucosal lymphocytes in nasal polyps |
| Q83185325 | Detection of Helicobacter pylori and cagA gene in nasal polyps and benign laryngeal diseases |
| Q81634646 | Detection of Helicobacter pylori in nasal polyps specimens using urease test GUT plus |
| Q83156479 | Detection of Helicobacter pylori in nasal polyps: preliminary report |
| Q77405343 | Detection of activated eosinophils in nasal polyps of an aspirin-induced asthma patient |
| Q85320056 | Detection of staphylococcal exotoxins in antrochoanal polyps and chronic rhinosinusitis with nasal polyps |
| Q71696902 | Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps |
| Q44442405 | Determination of free amino acid composition and enzyme activity of human nasal polyps in conditions of stimulation of serotonin biosynthesis |
| Q32125320 | Determination of proliferative activity in nasal polyps |
| Q28192596 | Determination of reactive oxygen species in nasal polyps |
| Q57029438 | Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size |
| Q30493265 | Diagnosis and treatment of nasal polyps |
| Q52324040 | Diagnostic Accuracy of Symptoms, Endoscopy, and Imaging Signs of Chronic Rhinosinusitis Without Nasal Polyps Compared to Allergic Rhinitis. |
| Q37406340 | Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity |
| Q83264405 | Diagnostic significance of blood eosinophil count in eosinophilic chronic rhinosinusitis with nasal polyps in Chinese adults |
| Q90867747 | Differences in cytokine levels between the nasal polyps of adolescents with local allergic and adolescents with allergic or nonallergic rhinitis |
| Q95585987 | Differences in expression of YKL-40 and TLR4 in nasal sinus mucosa of chronic sinusitis patients with and without nasal polyps |
| Q93185014 | Different effects of allergic rhinitis on nasal mucosa remodeling in chronic rhinosinusitis with and without nasal polyps |
| Q84882335 | Different expressions of erbB1/2 and tight junction proteins in hypertrophic inferior turbinates and nasal polyps |
| Q40357934 | Different roles of Staphylococcus aureus enterotoxin in different subtypes of nasal polyps |
| Q35648170 | Differential Expression and Release of Activin A and Follistatin in Chronic Rhinosinusitis with and without Nasal Polyps |
| Q47356157 | Differential Expression of the Aryl Hydrocarbon Receptor and Transforming Growth Factor Beta 1 in Chronic Rhinosinusitis with Nasal Polyps with Allergic Rhinitis |
| Q57279738 | Differential Hrd1 Expression and B-Cell Accumulation in Eosinophilic and Non-eosinophilic Chronic Rhinosinusitis With Nasal Polyps |
| Q85343206 | Differential expression of Livin, caspase-3, and second mitochondria-derived activator of caspases in chronic rhinosinusitis with nasal polyps |
| Q35605921 | Differential expression of interleukin-32 in chronic rhinosinusitis with and without nasal polyps |
| Q90705600 | Differential expression of miR-4492 and IL-10 is involved in chronic rhinosinusitis with nasal polyps |
| Q41511091 | Differential pathology of nasal polyps in cystic fibrosis and atopy |
| Q39951114 | Differential proteomic analysis of nasal polyps, chronic sinusitis, and normal nasal mucosa tissues |
| Q43205973 | Differential rates of proliferation and apoptosis in nasal polyps correspond to alterations in DNA spatial distribution and nuclear polarization as observed by confocal microscopy |
| Q38666686 | Differential short palate, lung, and nasal epithelial clone 1 suppression in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps: implications for pathogenesis and treatment |
| Q82457498 | Diffuse mucosal inflammation in nasal polyps and adjacent middle turbinate |
| Q94950089 | Direct and indirect costs of adult patients with chronic rhinosinusitis with nasal polyps |
| Q92745102 | Disconnect between effects of mepolizumab on severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps |
| Q87561953 | Disease-specific T-helper cell polarizing function of lesional dendritic cells in different types of chronic rhinosinusitis with nasal polyps |
| Q98281999 | Distinct Clinical Pathology and Microbiota in Chronic Rhinosinusitis With Nasal Polyps Endotypes |
| Q50854296 | Distinct characteristics of nasal polyps with and without eosinophilia. |
| Q54125357 | Distinct expression of NK2 homeobox 1 (NKX2-1) and goblet cell hyperplasia in nasal polyps with different endotypes. |
| Q102203294 | Distinct expression of SARS-CoV-2 receptor ACE2 correlates with endotypes of chronic rhinosinusitis with nasal polyps |
| Q48236442 | Distinct gene expression profiles and regulation networks of nasal polyps in eosinophilic and non-eosinophilic chronic rhinosinusitis |
| Q35657563 | Distinct inflammatory profiles in atopic and nonatopic patients with chronic rhinosinustis accompanied by nasal polyps in Western china |
| Q51461919 | Distinct mucosal immunopathologic profiles in atopic and nonatopic chronic rhinosinusitis without nasal polyps in Central China. |
| Q97422053 | Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma |
| Q57299769 | Distinctive expression profiles of Caveolin-1 and Notch-1 protein in patients with nasal polyps or sinonasal inverted papillomas |
| Q44717964 | Distribution of 3-nitrotyrosine in the nasal polyps of atopic patients |
| Q50527677 | Distribution of mast cells and eosinophils in nasal polyps from atopic and nonatopic subjects: a morphometric study. |
| Q77910001 | Distribution of rantes and interleukin-5 in allergic nasal mucosa and nasal polyps |
| Q53581752 | Do nasal polyps and inverted papilloma have similar disorders in cell cycle regulation? |
| Q44405506 | Do patients with chronic rhinosinusitis with nasal polyps suffer with facial pain? |
| Q80422974 | Does the prevalence of nasal polyps increase in patients using statins? |
| Q89919209 | Double-blind placebo-controlled randomized clinical trial of verapamil for chronic rhinosinusitis with nasal polyps |
| Q92971690 | Down-Expression of Kinin Receptors in Allergic Nasal Polyps Epithelia: An Immunohistochemistry Study |
| Q88107292 | Downregulation of caveolin-1 in chronic rhinosinusitis with and without nasal polyps |
| Q87351403 | Doxycycline or oral corticosteroids for nasal polyps |
| Q28192914 | Drug allergy among patients suffering from nasal polyps |
| Q92718851 | Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma |
| Q91510543 | Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps |
| Q95641851 | Dupilumab: Clinical Efficacy of Blocking IL-4/IL-13 Signalling in Chronic Rhinosinusitis with Nasal Polyps |
| Q92692911 | Dynamic Change of T-Helper Cell Cytokines in Nasal Secretions and Serum after Endoscopic Sinus Surgery in Chronic Rhinosinusitis with Nasal Polyps |
| Q28171128 | Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma |
| Q44109821 | Dysfunction of carbohydrate metabolism as an element in the set of factors resulting in the polysaccharide nose and nasal polyps (the polysaccharide nose). |
| Q85494051 | Dysregulated survivin expression in nasal polyps of individuals with aspirin exacerbated respiratory disease |
| Q84749655 | Dysregulation of E-cadherin in chronic rhinosinusitis with nasal polyps |
| Q81620165 | EAACI position paper on rhinosinusitis and nasal polyps executive summary |
| Q80816963 | EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists |
| Q83792713 | EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists |
| Q34774266 | EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary. |
| Q102331417 | EUFOREA Expert Board Meeting on Uncontrolled Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Biologics: Definitions and Management |
| Q91794649 | EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps |
| Q104275826 | Effect of Benralizumab in Patients With Severe Eosinophilic Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Case Series |
| Q89546641 | Effect of ESS on Olfactory Threshold of Patients with CRS without Nasal Polyps |
| Q43210866 | Effect of clarithromycin on the expressions of cyclooxygenase-2 and nuclear factor-kappa B in nasal polyps in vitro |
| Q48056384 | Effect of distribution of nasal polyps in ostiomeatal complex on long-term outcomes after endoscopic surgery |
| Q81343150 | Effect of glucocorticoid on the MUC4 gene in nasal polyps |
| Q35622585 | Effect of lipopolysaccharide on glucocorticoid receptor function in control nasal mucosa fibroblasts and in fibroblasts from patients with chronic rhinosinusitis with nasal polyps and asthma. |
| Q73927201 | Effect of macrolides on the expression of HLA-DR and costimulatory molecules on antigen-presenting cells in nasal polyps |
| Q50467602 | Effect of mitomycin C on the secretion of granulocyte macrophages colonies stimulating factor and interleukin-5 in eosinophilic nasal polyps stromal culture. |
| Q91589321 | Effect of monoclonal antibodies on olfactory dysfunction caused by chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis |
| Q71537742 | Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis |
| Q73040010 | Effect of prednisolone on cytokine synthesis in nasal polyps |
| Q79093765 | Effect of proinflammatory cytokines on human leucocyte antigen expression of epithelial cells of nasal polyps |
| Q96606806 | Effect of short-course glucocorticoid application on patients with chronic rhinosinusitis with nasal polyps |
| Q46067815 | Effect of statins on fibroblasts from human nasal polyps and turbinates. |
| Q96822034 | Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis |
| Q87611687 | Effects of IL-17 on expression of GRO-α and IL-8 in fibroblasts from nasal polyps |
| Q91334784 | Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps |
| Q79205464 | Effects of corticosteroid on eosinophils and expression of transforming growth factor beta 1 in nasal polyps |
| Q84241328 | Effects of dexamethasone or methotrexate on chitinolytic activity in nasal polyps |
| Q31160947 | Effects of irrigating solution of Sihuang on morphology and function of nasal mucosa following surgery for chronic sinusitis and nasal polyps |
| Q79205452 | Effects of taking the pingzhi tablets on cellular infiltration in tissues of nasal polyps |
| Q89941328 | Effects of the first three doses of benralizumab on symptom control, lung function, blood eosinophils, oral corticosteroid intake, and nasal polyps in a patient with severe allergic asthma |
| Q90205200 | Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trial |
| Q94541128 | Efficacy of Budesonide Nasal Spray on Neutrophilic Chronic Rhinosinusitis with Nasal Polyps: A Combined Clinical and Experimental Study |
| Q93105963 | Efficacy of Dexamethasone Versus Fluticasone Nasal Sprays in Postoperative Patients With Chronic Rhinosinusitis With Nasal Polyps |
| Q89862618 | Efficacy of Mepolizumab Treatment on Oral Corticosteroid-Dependent Severe Eosinophilic Asthma Patients with Chronic Rhinosinusitis with Nasal Polyps: Single Center Real Life Study |
| Q92319747 | Efficacy of Short-Term Systemic Corticosteroid Therapy in Chronic Rhinosinusitis With Nasal Polyps: A Meta-Analysis of Randomized Controlled Trials and Systematic Review |
| Q74754669 | Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps |
| Q96293740 | Efficacy of buffered hypertonic seawater in different phenotypes of chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery: a randomized double-blind study |
| Q99631070 | Efficacy of corticosteroid solution administration via Mygind's position for the management of chronic rhinosinusitis with nasal polyps |
| Q91301557 | Efficacy of lianhuaqingwen granules in the management of chronic rhinosinusitis without nasal polyps |
| Q53073784 | Efficacy of long-term low-dose macrolide therapy in preventing early recurrence of nasal polyps after endoscopic sinus surgery. |
| Q92201033 | Efficacy of mometasone furoate for nasal polyps: A protocol for systematic review of randomized controlled trial |
| Q92887735 | Efficacy of posterior nasal neurectomy for allergic rhinitis combined with chronic rhinosinusitis with nasal polyps |
| Q72331403 | Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide |
| Q91340802 | Elastase-Positive Neutrophils Are Associated With Refractoriness of Chronic Rhinosinusitis With Nasal Polyps in an Asian Population |
| Q57803336 | Elevated IgE M1 prime transcripts in nasal tissues in patients with nasal polyps and asthma |
| Q59800226 | Elevated expression of IL-17RB and ST2 on myeloid dendritic cells is associated with a Th2-skewed eosinophilic inflammation in nasal polyps |
| Q35741834 | Elevated presence of myeloid dendritic cells in nasal polyps of patients with chronic rhinosinusitis |
| Q104559089 | Endoplasmic reticulum stress exacerbates inflammation in chronic rhinosinusitis with nasal polyps via the transcription factor XBP1 |
| Q103835653 | Endoscopic polypectomy performed in clinic for chronic rhinosinusitis with nasal polyps: study protocol for the EPIC multicentre randomised controlled trial |
| Q47831591 | Endoscopic removal of nasal polyps in a cat using a novel surgical approach. |
| Q89358283 | Endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps: Clinical outcome and predictive factors of recurrence |
| Q70896791 | Endoscopic sinus surgery for nasal polyps in children: results |
| Q33261492 | Endoscopic sinus surgery for the excision of nasal polyps: A systematic review of safety and effectiveness |
| Q37602537 | Endoscopic sinus surgery in adult patients with chronic rhinosinusitis with nasal polyps (PolypESS): study protocol for a randomised controlled trial |
| Q74143589 | Endoscopic view of the sites of origin of nasal polyps |
| Q83305372 | Endothelial and epithelial expression of eotaxin-2 (CCL24) in nasal polyps |
| Q90685546 | Endotypes of Chronic Rhinosinusitis with Nasal Polyps: Pathology and Possible Therapeutic Implications |
| Q97640078 | Endotypes of chronic rhinosinusitis with nasal polyps with and without NSAID - intolerance |
| Q99552898 | Enhanced Type 2 Immune Reactions by Increased IL-22/IL-22Ra1 Signaling in Chronic Rhinosinusitis With Nasal Polyps |
| Q91219206 | Enhanced recovery after surgery protocols in functional endoscopic sinus surgery for patients with chronic rhinosinusitis with nasal polyps: a randomized clinical trial |
| Q33266379 | Eosinophil chemoattractants and related factors in nasal polyps |
| Q51525575 | Eosinophil chemotaxis assay in nasal polyps by using a novel optical device EZ-TAXIScan: Role of CC-chemokine receptor 3. |
| Q71695081 | Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps |
| Q81309892 | Eosinophil infiltration of nasal polyps in patients with nasal polyposis: role in clinical evolution after medical and surgical treatment |
| Q64039406 | Eosinophilic Granulomatosis with Polyangiitis Manifesting as Recurrent Nasal Polyps and Hemorrhagic Necrotic Bullae: A Rare Disease Successfully Treated with Azathioprine |
| Q53064278 | Eosinophilic inflammation of chronic rhinosinusitis with nasal polyps is related to OX40 ligand expression. |
| Q52932197 | Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3. |
| Q70568770 | Eosinophils in nasal polyps and nasal mucosa: an immunohistochemical study |
| Q51762003 | Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients. |
| Q61800043 | Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis |
| Q24614953 | Epidemiology and differential diagnosis of nasal polyps |
| Q96231297 | Epidermal growth factor upregulates expression of MUC5AC via TMEM16A, in chronic rhinosinusitis with nasal polyps |
| Q91916810 | Epithelial Squamous Metaplasia and Dysplasia in Inflammatory Nasal Polyps: An Observational Study |
| Q89485067 | Epithelial activators of type 2 inflammation: Elevation of thymic stromal lymphopoietin, but not IL-25 or IL-33, in chronic rhinosinusitis with nasal polyps in Chicago, Illinois |
| Q77670868 | Epithelial atypia and squamous metaplasia in nasal polyps |
| Q71073458 | Epithelial cell proliferation in nasal polyps could be up-regulated by platelet-derived growth factor |
| Q71388112 | Epithelial damage in nasal polyps |
| Q42067597 | Epithelial genes in chronic rhinosinusitis with and without nasal polyps |
| Q39619617 | Epithelial-Mesenchymal Transition in Chronic Rhinosinusitis: Differences Revealed Between Epithelial Cells from Nasal Polyps and Inferior Turbinates |
| Q93027859 | Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps |
| Q67715169 | Erosion of the pituitary fossa by benign nasal polyps |
| Q94646973 | Erratum: In-Depth, Proteomic Analysis of Nasal Secretions from Patients With Chronic Rhinosinusitis and Nasal Polyps |
| Q92727781 | Escalation in mucus cystatin 2, pappalysin-A, and periostin levels over time predict need for recurrent surgery in chronic rhinosinusitis with nasal polyps |
| Q90270886 | Establishing a Therapeutic Strategy Targeting NF-κB in Asian Patients with Chronic Rhinosinusitis With Nasal Polyps |
| Q33256275 | Establishment of 2-dimensional gel electrophoresis map and analysis of proteomics from human nasal polyps |
| Q45412042 | Etiology of nasal polyps associated with aspirin-sensitive asthma |
| Q30417357 | Etiology of nasal polyps in cystic fibrosis: not a unimodal disease |
| Q71602673 | Etiopathogenesis of nasal polyps |
| Q59154698 | European Position Paper on Rhinosinusitis and Nasal Polyps |
| Q81338553 | European Position Paper on Rhinosinusitis and Nasal Polyps |
| Q34640008 | European Position Paper on Rhinosinusitis and Nasal Polyps 2012. |
| Q89797585 | European Position Paper on Rhinosinusitis and Nasal Polyps 2020 |
| Q34685273 | European position paper on rhinosinusitis and nasal polyps 2007. |
| Q28272856 | Evaluation of ECP release from intact tissue biopsies from patients with nasal polyps |
| Q91369579 | Evaluation of a Dermoplasty Technique for the Control on Nasal Polyps |
| Q47307488 | Evaluation of a novel natural drop for treatment of chronic rhinosinusitis without nasal polyps: a single blind randomized trial. |
| Q84562074 | Evaluation of long-term clarithromycin treatment in adult Chinese Patients with chronic rhinosinusitis without nasal polyps |
| Q45067674 | Evaluation of patients with nasal polyps about the possible association of desmosomal junctions, RORA and PDE4D gene |
| Q80875306 | Evaluation of telomerase activity in nasal polyps |
| Q95647184 | Evaluation of the effect of endoscopic partial middleturbinectomy surgery on the quality of life of patients with chronic rhinosinusitis and nasal polyps |
| Q92457105 | Evaluation of the frequency of invariant natural killer T (iNKT) cells in nasal polyps |
| Q48365441 | Evaluation of the olfactory bulb volume and olfactory threshold in patients with nasal polyps and impact of functional endoscopic sinus surgery: a longitudinal study |
| Q81673972 | Evidence based diagnosis and treatment of rhinosinusitis and nasal polyps |
| Q30424781 | Evidence for distinct histologic profile of nasal polyps with and without eosinophilia |
| Q36062767 | Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps |
| Q104738338 | Evidence for role of acid-sensing ion channel 1a in chronic rhinosinusitis with nasal polyps |
| Q89491119 | Evidence for the Presence of Long-Lived Plasma Cells in Nasal Polyps |
| Q33573926 | Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps |
| Q36605041 | Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression |
| Q91471051 | Excessive periostin expression and Th2 response in patients with nasal polyps: association with asthma |
| Q90093905 | Exhalation Delivery System: Novel Device for Nasal Polyps Treatment |
| Q47702759 | Exhaled and nasal nitric oxide in chronic rhinosinusitis patients with nasal polyps in primary care |
| Q104066184 | Exosomal miR-22-3p Derived from Chronic Rhinosinusitis with Nasal Polyps Regulates Vascular Permeability by Targeting VE-Cadherin |
| Q91921183 | Expert-level diagnosis of nasal polyps using deep learning on whole-slide imaging |
| Q88483569 | Expression and Functional Analysis of CST1 in Intractable Nasal Polyps |
| Q36064065 | Expression and Regulation of Interleukin-37 in Pathogenesis of Nasal Polyps |
| Q53547112 | Expression and distribution of aquaporin-1 in nasal polyps: does it have any significance in edema formation? |
| Q87628343 | Expression and regulation of osteopontin in chronic rhinosinusitis with nasal polyps |
| Q85099106 | Expression and significance of STAT3 and VEGF with MVD in the nasal polyps |
| Q54409337 | Expression and significance of surfactant A in nasal polyps of chronic rhinosinusitis |
| Q78756204 | Expression and significance of the vascular permeability factor in nasal polyps |
| Q30767132 | Expression and significance of vascular permeability factor in nasal polyps |
| Q43112765 | Expression of 3-nitrotyrosine, a marker for peroxynitrite, in nasal polyps of nonatopic patients. |
| Q28196323 | Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma |
| Q89057698 | Expression of ADAM17 and ADAM10 in nasal polyps |
| Q79093771 | Expression of CD68 CD45RO CD20 and proliferating cell nuclear antigen in nasal polyps |
| Q92340531 | Expression of COX-1, COX-2, 5-LOX and CysLT2 in nasal polyps and bronchial tissue of patients with aspirin exacerbated airway disease |
| Q93217930 | Expression of Cl- channels/transporters in nasal polyps |
| Q104610155 | Expression of Estrogen Receptor-alpha in Nasal Polyps and the Effects of Dexamethasone on Estrogen Receptor-alpha Expression in RPMI 2650 Cells |
| Q47974587 | Expression of IGF-1R and iNOS in nasal polyps; epithelial cell homeostasis and innate immune mechanisms in pathogenesis of nasal polyposis |
| Q50599485 | Expression of IL-17 and syndecan-1 in nasal polyps and their correlation with nasal polyps. |
| Q36464504 | Expression of MMP-9/TIMP-2 in nasal polyps and its functional implications |
| Q92364551 | Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Chronic Rhinosinusitis With Nasal Polyps: Etiopathogenesis and Recurrence |
| Q103017158 | Expression of T helper cytokines associated with MUC5AC secretion in eosinophil-based endotypes of nasal polyps |
| Q86549836 | Expression of a disintegrin and metalloproteinase 8 by inflammatory cells in nasal polyps |
| Q46034358 | Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics. |
| Q28219309 | Expression of cyclooxygenase and lipoxygenase enzymes in nasal polyps of aspirin-sensitive and aspirin-tolerant patients |
| Q50514278 | Expression of cyclooxygenase in nasal polyps from atopic and nonatopic subjects. |
| Q53583662 | Expression of cyclooxygenase-2 and 5-lipoxygenase in nasal polyps associated with interleukin-4 promoter polymorphism -590. |
| Q77517265 | Expression of glucocorticoid receptors and cyclooxygenase-2 in nasal polyps from nonallergic patients |
| Q45985657 | Expression of glutaredoxin-1 in nasal polyps and airway epithelial cells. |
| Q58178398 | Expression of guanylin and uroguanylin mRNA in human nasal mucosa and nasal polyps |
| Q87176884 | Expression of heme oxygenase-1 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps: modulation by cytokines |
| Q81701849 | Expression of hypoxia-inducible factor 1alpha in the nasal polyps by real-time RT-PCR and immunohistochemistry |
| Q47878482 | Expression of intercellular adhesion molecule-1 on the vascular endothelium in nasal polyps before, during and after topical glucocorticoid treatment |
| Q84117368 | Expression of leptin receptor in nasal polyps: leptin as a mucosecretagogue |
| Q86054627 | Expression of leukotriene and its receptors in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q90838294 | Expression of long pentraxin 3 in human nasal mucosa fibroblasts, tissues, and secretions of chronic rhinosinusitis without nasal polyps |
| Q54536904 | Expression of mammaglobins A and B in nasal polyps is similar in patients with and without allergic rhinitis. |
| Q89692537 | Expression of nicotinamide adenine dinucleotide phosphate oxidase in chronic rhinosinusitis with nasal polyps |
| Q80860887 | Expression of survivin and enhanced polypogenesis in nasal polyps |
| Q73213342 | Expression of tenascin and fibronectin in nasal polyps |
| Q77726510 | Expression of the transforming growth factor beta isoforms in inflammatory cells of nasal polyps |
| Q74314142 | Expression of transforming growth factor-beta 1 and alpha-smooth muscle actin of myofibroblast in the pathogenesis of nasal polyps |
| Q30936546 | Expression of vascular endothelial growth factor and transforming growth factor-beta 1 in nasal polyps |
| Q71709601 | Expression of vasoactive intestinal peptide, substance P and bombesin-flanking peptide in nasal polyps |
| Q82691786 | Expression pattern of CK7 and CK20 in nasal polyps, at patients with chronic rhinosinusitis with nasal polyposis |
| Q47826645 | Expression patterns of galectin-1 and galectin-3 in nasal polyps and middle and inferior turbinates in relation to growth regulation and immunosuppression. |
| Q33213790 | Expression profile of immune associated genes in nasal polyps |
| Q100683500 | Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma |
| Q47856217 | Extensive versus functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps and asthma: A 1-year study |
| Q50095467 | Factors Affecting Time to Revision Sinus Surgery for Nasal Polyps: A 25-Year Experience |
| Q86861082 | Factors affecting time to revision sinus surgery for nasal polyps: a 25-year experience |
| Q83150535 | Factors associated with recurrent nasal polyps: a tertiary care experience |
| Q69468424 | Familial Occurrence of Asthma, Nasal Polyps, and Aspirin Intolerance |
| Q47965379 | Fibroblast levels are increased in chronic rhinosinusitis with nasal polyps and are associated with worse subjective disease severity |
| Q72133703 | Fine Structure of the Plasma Cell in the Nasal Polyp |
| Q67280104 | Fine structure of nasal polyps |
| Q71785789 | Flexible fiberoptic rhinoscopy in the diagnosis of nasal polyps in cystic fibrosis |
| Q84563860 | Flurbiprofen axetil, nasal polyps, and status asthmaticus: an unusual case report |
| Q45043932 | Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery |
| Q90234842 | Food-Specific IgE and IgG Antibodies in Patients With Chronic Rhinosinusitis With Nasal Polyps: A Case-Control Study |
| Q95566047 | For a few years now I've had nasal stuffiness, decreased sense of smell and headaches. I recently found that nasal polyps are probably responsible for my symptoms. What are my treatment options? |
| Q81165528 | For a few years now I've had nasal stuffiness, decreased sense of smell, and headaches. I recently found out nasal polyps are probably responsible for my symptoms. What are my treatment options? |
| Q90131049 | Formation of nasal polyps: The roles of innate type 2 inflammation and deposition of fibrin |
| Q44604729 | Foxp3+ T regulatory cells (Tregs) are increased in nasal polyps (NP) after treatment with intranasal steroid |
| Q53152776 | Frequency of fungal isolation and antifungal susceptibility pattern of the fungal isolates from nasal polyps of chronic rhinosinusitis patients at a tertiary care centre in north India. |
| Q83195844 | Frontal sinus pneumocele associated with respiratory epithelial adenomatoid hamartoma and nasal polyps |
| Q37943847 | Fungi linking the pathophysiology of chronic rhinosinusitis with nasal polyps and allergic asthma |
| Q43890804 | Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration |
| Q60191910 | Gene expression analysis reveals novel altered genes in nasal polyps |
| Q51569880 | Gene expression profiles of nasal polyps associated with allergic rhinitis. |
| Q46662092 | Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma |
| Q33631215 | Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis |
| Q37521796 | Gene-expression signatures of nasal polyps associated with chronic rhinosinusitis and aspirin-sensitive asthma |
| Q57990952 | Genetic influences in the formation of nasal polyps |
| Q39811129 | Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics |
| Q34270916 | Glandular mast cells with distinct phenotype are highly elevated in chronic rhinosinusitis with nasal polyps |
| Q84344489 | Glucocorticoid receptor expression and glucocorticoid therapeutic effect in nasal polyps |
| Q84765464 | Glucocorticoid receptor immunoreactivity of eosinophils in nasal polyps |
| Q46104726 | Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo |
| Q44259827 | Glucocorticoid-induced differential expression of the sialylated and nonsialylated Lewis(a) epitopes and respective binding sites in human nasal polyps maintained under ex vivo tissue culture conditions |
| Q91358330 | Glucocorticoids ameliorate periostin-induced tissue remodeling in chronic rhinosinusitis with nasal polyps |
| Q28369185 | Glucocorticoids decrease c-fos expression in human nasal polyps in vivo |
| Q73917831 | Glycohistochemical characteristics of nasal polyps from patients with and without cystic fibrosis |
| Q58084146 | Glycosoaminoglycans in nasal polyps |
| Q51074774 | Group 2 innate lymphoid cells (ILC2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia. |
| Q51638404 | Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis. |
| Q80498971 | Group II subfamily secretory phospholipase A2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps |
| Q44624234 | Growth Factors and Receptors in Juvenile Nasopharyngeal Angiofibroma and Nasal Polyps: An Immunohistochemical Study |
| Q74516039 | Growth inhibition of fibroblasts from nasal polyps and normal skin by lysine acetylsalicylate |
| Q73978644 | Growth-related oncogene-alpha expression in human nasal polyps |
| Q96136266 | Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: Discussion from an NIH sponsored workshop |
| Q82516751 | HIF-1alpha and CA IX expression in nasal polyps and study on their correlation |
| Q98776246 | HIF-1α induces NLRP3 expression by M1 macrophages in non-eosinophilic chronic rhinosinusitis with nasal polyps |
| Q78502084 | HISTOMORPHOLOGY AND HISTOCHEMISTRY OF NASAL POLYPS IN RELATION TO THEIR ETIOLOGY AND PATHOGENESIS |
| Q71294655 | HLA antigens, nasal polyps and asthma |
| Q66959460 | Haemorrhagic nasal polyps of the horse |
| Q59293628 | Health outcomes, education, healthcare delivery and quality – 3040. Occurrence and effects of nasal polyps in patients with bronchial asthma and/or allergic rhinitis |
| Q104568632 | Health-related quality of life and drug treatment satisfaction were low and correlated negatively with symptoms in patients having severe refractory chronic rhinosinusitis with nasal polyps |
| Q90219478 | Hemokinin-1 stimulates C-C motif chemokine ligand 24 production in macrophages to enhance eosinophilic inflammation in nasal polyps |
| Q49769504 | Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois. |
| Q109044015 | High CT values relative to the brainstem differentiate inverted papillomas from nasal polyps |
| Q90355481 | High frequency of macrophages expressing elevated level of CD80, PD-Ls and TLR1 in nasal polyps of CRS patients |
| Q86932602 | High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps |
| Q57180963 | Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement |
| Q90851584 | Highly multiplexed proteomic analysis reveals significant tissue and exosomal coagulation pathway derangement in chronic rhinosinusitis with nasal polyps |
| Q72736554 | Histamine and its Release from Nasal Polyps: Preliminary Communication |
| Q70546962 | Histamine metabolism in nasal polyps |
| Q72528772 | Histamine, asthma, and nasal polyps |
| Q36833840 | Histochemical detection of expression of binding sites for labelled hyaluronic acid and carrier-immobilized synthetic (histo-blood group trisaccharides) or biochemically purified (ganglioside GM1) glycoligands in nasal polyps and other human lesions |
| Q78688589 | Histochemical studies of the pathogenesis of nasal polyps |
| Q42442622 | Histochemical study of the epithelia of nasal polyps by biotinylated lectins and neoglycoprotein. A comparison with the normal human respiratory epithelium |
| Q68733207 | Histochemical study on innervation of glands and blood vessels in nasal polyps |
| Q74415008 | Histological analysis of nasal polyps in children |
| Q53070764 | Histological characteristics of chronic rhinosinusitis with nasal polyps: Recent 10-year experience of a single center in Daegu, Korea. |
| Q71211848 | Histology of nasal polyps in various conditions |
| Q52859301 | Histology of nasal polyps of different etiology |
| Q71466556 | Histopathological Examinations of nasal polyps of different etiology |
| Q38199549 | Histopathological characteristics of nasal polyps in smokers and non-smokers |
| Q28209963 | Histopathological features of nasal polyps with asthma association: an immunohistochemical study |
| Q35913550 | Human IL-21+IFN-γ+CD4+ T cells in nasal polyps are regulated by IL-12. |
| Q40167576 | Human ciliated epithelial cells from nasal polyps as an experimental model for Mycoplasma pneumoniae infection |
| Q39751390 | Human papillomavirus infection in nasal polyps in a Chinese population |
| Q73676051 | Human respiratory cells from nasal polyps as a model for gene transfer by non-viral cationic vectors |
| Q36753965 | Humanized mouse model used to monitor MUC gene expression in nasal polyps and to preclinically evaluate the efficacy of montelukast in reducing mucus production |
| Q40589592 | Hyaluronan and a-Atrial Natriuretic Polypeptide in Human Nasal Polyps: Contributing Factors to Oedema Formation and Polyp Growth? |
| Q92077399 | Hypomethylation of the IL8 promoter in nasal epithelial cells of patients with chronic rhinosinusitis with nasal polyps |
| Q90217337 | IFN-λ1 enhances Staphylococcus aureus clearance in healthy nasal mucosa but not in nasal polyps |
| Q39511112 | IL-22/IL-22R1 signaling regulates the pathophysiology of chronic rhinosinusitis with nasal polyps via alteration of MUC1 expression |
| Q53600380 | IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis. |
| Q36857733 | IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa |
| Q47351617 | IL-33 Expression in Chronic Rhinosinusitis with Nasal Polyps and Its Relationship with Clinical Severity |
| Q33738493 | IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps |
| Q81486555 | IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration |
| Q46028624 | IL-5, IL-8 and tgf-beta expressions in chronic rhinosinusitis patients with nasal polyps and their correlation to tissue's cellularity and disease relapsing. |
| Q44603260 | IL‐11 and IL‐17 expression in nasal polyps: Relationship to collagen deposition and suppression by intranasal fluticasone propionate |
| Q89668572 | Identification of Key Modules, Hub Genes, and Noncoding RNAs in Chronic Rhinosinusitis with Nasal Polyps by Weighted Gene Coexpression Network Analysis |
| Q55174051 | Identification of Selective Basophil Chemoattractants in Human Nasal Polyps as Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor-2 |
| Q54377489 | Identification of bacteria isolated from nasal polyps and their ability to produce superantigens and biofilms in Lebanese patients. |
| Q91129804 | Identification of key genes and pathways in chronic rhinosinusitis with nasal polyps using bioinformatics analysis |
| Q90918624 | IgD-activated mast cells induce IgE synthesis in B cells in nasal polyps |
| Q100992108 | Immune cell infiltration and related core genes expression characteristics in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps |
| Q33786954 | Immune imbalance in nasal polyps of Caucasian chronic rhinosinusitis patients is associated with a downregulation of E-selectin |
| Q72644974 | Immunocompetent cells in human nasal polyps and normal mucosa |
| Q73584066 | Immunocytochemical distribution of the c-H-ras protein in nasal polyps: localization to the terminal bars |
| Q66902619 | Immunofluorescence studies on renal tissue, tonsils, adenoids, nasal polyps, and skin of atopic and nonatopic patients, with special reference to IgE |
| Q69349116 | Immunofluorescent Localization of Immunoglobulins in Nasal Polyps |
| Q45113890 | Immunoglobulins in allergic nasal polyps |
| Q80933517 | Immunohistochemical demonstration and semi-quantitation of vascular endothelial growth factor in recurrent versus non-recurrent nasal polyps |
| Q74454943 | Immunohistochemical expression of VEGF and VEGF receptors in nasal polyps as compared to normal turbinate mucosa |
| Q80383863 | Immunohistochemical localization of eotaxin immunoreactivity in nasal polyps |
| Q80450315 | Immunolocalisation of heme oxygenase isoforms in human nasal polyps |
| Q92101160 | Immunological Characteristics in Refractory Chronic Rhinosinusitis with Nasal Polyps Undergoing Revision Surgeries |
| Q90944665 | Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps |
| Q35694392 | Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations |
| Q51010195 | Immunopathologic characteristics of nasal polyps in adult Koreans: A single-center study. |
| Q68945003 | Immunopathological characteristics of nasal polyps |
| Q67461671 | Immunopathology of nasal polyps |
| Q69402576 | Immunopathology of nasal polyps: an immunohistochemical approach |
| Q93003754 | Impact of Allergy and Eosinophils on the Morbidity of Chronic Rhinosinusitis with Nasal Polyps in Northwest China |
| Q82723393 | Impact of cell culture methods on the outcomes of the in vitro inflammatory response in nasal polyps |
| Q36259930 | Impact of nasal polyps on quality of life of chronic sinusitis patients |
| Q82751264 | Impact of ozone exposure on prostaglandin release in nasal polyps |
| Q89490983 | Impact of the Long-Lived Plasma Cells in Patients With Chronic Rhinosinusitis With Nasal Polyps |
| Q100311242 | Impaired small airway function in non-asthmatic chronic rhinosinusitis with nasal polyps |
| Q61442730 | In vitro effect of glucocorticoids on nasal polyps |
| Q92101217 | In-Depth, Proteomic Analysis of Nasal Secretions from Patients With Chronic Rhinosinusitis and Nasal Polyps |
| Q92223268 | In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis |
| Q81028090 | Incidence and evolution of nasal polyps in children and adolescents with cystic fibrosis |
| Q67972437 | Incidence of medico-surgical treatment for nasal polyps on the development of associated asthma |
| Q87248500 | Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q50981782 | Increased BAFF expression in nasal polyps is associated with local IgE production, Th2 response and concomitant asthma. |
| Q104615054 | Increased Expression of TXNIP Facilitates Oxidative Stress in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis With Nasal Polyps |
| Q91878541 | Increased Expressions and Roles of CC Chemokine Ligand 21 and CC Chemokine Ligand 25 in Chronic Rhinosinusitis with Nasal Polyps |
| Q98172284 | Increased Serum Periostin Levels and Eosinophils in Nasal Polyps Are Associated with the Preventive Effect of Endoscopic Sinus Surgery for Asthma Exacerbations in Chronic Rhinosinusitis Patients |
| Q93263207 | Increased Tissue Expression of Lectin-Like Oxidized LDL Receptor-1 (LOX-1) Is Associated with Disease Severity in Chronic Rhinosinusitis with Nasal Polyps |
| Q90661018 | Increased accumulation of CD30 ligand-positive mast cells associates with eosinophilic inflammation in nasal polyps |
| Q74415878 | Increased eotaxin-mRNA expression in non-atopic and atopic nasal polyps: comparison to RANTES and MCP-3 expression |
| Q74247996 | Increased epithelial cell proliferation in nasal polyps |
| Q87425707 | Increased expression of chemokine receptors CCR1 and CCR3 in nasal polyps: molecular basis for recruitment of the granulocyte infiltrate |
| Q73444119 | Increased expression of matrix metalloproteinase-9 in nasal polyps |
| Q91046011 | Increased expression of pendrin in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q35085607 | Increased expression of the chemokine CCL23 in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q36372767 | Increased expression of the epithelial anion transporter pendrin/SLC26A4 in nasal polyps of patients with chronic rhinosinusitis |
| Q86822480 | Increased expression of transcription factor Bcl-6 in chronic rhinosinusitis with nasal polyps |
| Q71668702 | Increased in vitro cysteinyl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance |
| Q98879989 | Increased lipopolysaccharide content is positively correlated with glucocorticoid receptor-beta expression in chronic rhinosinusitis with nasal polyps |
| Q33580012 | Increased local IgE production induced by common aeroallergens and phenotypic alteration of mast cells in Chinese eosinophilic, but not non-eosinophilic, chronic rhinosinusitis with nasal polyps |
| Q83768627 | Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy |
| Q35071272 | Increased noneosinophilic nasal polyps in chronic rhinosinusitis in US second-generation Asians suggest genetic regulation of eosinophilia. |
| Q89049152 | Increased phosphorylation of eNOS in nasal polyps of chronic rhinosinusitis patients can be diminished by 1,8-cineol |
| Q83354746 | Increased presence of dendritic cells and dendritic cell chemokines in the sinus mucosa of chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis |
| Q87380614 | Increased risk of psoriasis following chronic rhinosinusitis without nasal polyps: a population-based matched-cohort study |
| Q92226619 | Increased risk of psoriasis in patients with chronic rhinosinusitis without nasal polyps: a longitudinal follow-up study using Korean national sample cohort |
| Q47361796 | Increased serum amyloid A in nasal polyps is associated with systemic corticosteroid insensitivity in patients with chronic rhinosinusitis with nasal polyps: a pilot study. |
| Q90342671 | Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps |
| Q84803564 | Indoleamine 2,3-dioxygenase expression is associated with chronic rhinosinusitis with nasal polyps and antrochoanal polyps |
| Q50438798 | Induction of nasal polyps using house dust mite and Staphylococcal enterotoxin B in C57BL/6 mice. |
| Q79862052 | Infarcted angiomatous nasal polyps |
| Q45395683 | Infection rate and virus-induced cytokine secretion in experimental rhinovirus infection in mucosal organ culture: comparison between specimens from patients with chronic rhinosinusitis with nasal polyps and those from normal subjects |
| Q79069999 | Infectious and allergic nasal polyps |
| Q58174284 | Inflammatory Cytokine Expression on Nasal Polyps Developed in Allergic and Infectious Rhinitis |
| Q84540551 | Inflammatory cell types in nasal polyps |
| Q73520121 | Inflammatory cells as well as epithelial cells in nasal polyps express vascular endothelial growth factor |
| Q73386099 | Inflammatory cells in nasal mucosa and nasal polyps |
| Q100432892 | Inflammatory features and predictors for postsurgical outcomes in patients with nasal polyps stratified by local and systemic eosinophilia |
| Q92646338 | Inflammatory infiltration and tissue remodeling in nasal polyps and adjacent mucosa of unaffected sinus |
| Q36350621 | Inflammatory nasal polyps: an unusual late complication of Silastic sheet repair of orbital floor fracture |
| Q44507319 | Influence of rhinologic usual and unusual drugs on fibroblasts from nasal polyps in cell culture |
| Q49375254 | Influence of the location of nasal polyps on olfactory airflow and olfaction. |
| Q93209784 | Inhibition of arachidonate 15-lipoxygenase reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q96647416 | Injection of Steroid in Nasal Polyps: A Systematic Review |
| Q93639610 | Innervation of human nasal polyps |
| Q68516222 | Insulin-like growth factor I is a possible pathogenic mechanism in nasal polyps |
| Q77319778 | Interaction between fibronectin and eosinophils in the growth of nasal polyps |
| Q45153017 | Intercellular adhesion molecule-1 expression in nasal polyps treated with corticosteroid |
| Q28211650 | Interfacing medical and surgical management for chronic rhinosinusitis with and without nasal polyps |
| Q73335333 | Interferon gamma expression in human nasal polyps |
| Q79083567 | Interleukin (IL)-4 and to a lesser extent either IL-13 or interferon-gamma regulate the production of eotaxin-2/CCL24 in nasal polyps |
| Q24303583 | Interleukin 5, IL6, IL12, IFN-gamma, RANTES and Fractalkine in human nasal polyps, turbinate mucosa and serum |
| Q98162425 | Interleukin-17A Expression Correlated with the Prognosis of Chronic Rhinosinusitis with Nasal Polyps and the Anti-Interleukin-17A Effect in a Murine Nasal Polyps Model |
| Q35180720 | Interleukin-17A promotes MUC5AC expression and goblet cell hyperplasia in nasal polyps via the Act1-mediated pathway |
| Q50450335 | Interleukin-17A-induced inflammation does not influence the development of nasal polyps in murine model. |
| Q35021264 | Interleukin-1β regulates the expression of glucocorticoid receptor isoforms in nasal polyps in vitro via p38 MAPK and JNK signal transduction pathways |
| Q73555976 | Interleukin-3 interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps |
| Q91512359 | Interleukin-33 Promotes Th2/Th17 Response in Eosinophilic and Non-Eosinophilic Nasal Polyps |
| Q47409698 | Interleukin-33 promotes the inflammatory reaction in chronic rhinosinusitis with nasal polyps by NF-κB signaling pathway |
| Q53585964 | Interleukin-4 C-590T polymorphism is associated with protection against nasal polyps in a Korean population. |
| Q73889104 | Interleukin-8 expression in human nasal polyps |
| Q92693808 | Interleukins in nasal polyps and nasopharyngeal carcinoma |
| Q51658780 | Intracellular residency of Staphylococcus aureus within mast cells in nasal polyps: A novel observation. |
| Q87910957 | Intralesional bleomycin A5 injection for the treatment of nasal polyps through inducing apoptosis |
| Q70261330 | Intranasal beclomethasone in severe rhinosinusitis and nasal polyps |
| Q81327441 | Investigation of fungi in massive nasal polyps: microscopy, culture, polymerase-chain reaction, and serology |
| Q42224352 | Investigation of the role of major respiratory viruses in the aetiology of nasal polyps using polymerase chain reaction technique |
| Q75875616 | Investigations on nasal polyps and their genesis; a preliminary report |
| Q38128553 | Is routine histological examination of nasal polyps justified? |
| Q91652482 | JESREC score and mucosal eosinophilia can predict endotypes of chronic rhinosinusitis with nasal polyps |
| Q28287197 | Keratinocyte growth factor and its receptor messenger RNA expression in nasal mucosa and nasal polyps |
| Q91694764 | LL-37 promotes neutrophil extracellular trap formation in chronic rhinosinusitis with nasal polyps |
| Q30252446 | Lack of Efficacy of Symptoms and Medical History in Distinguishing the Degree of Eosinophilia in Nasal Polyps |
| Q83398274 | Lack of association between aspirin-triggered 15-hydroxyeicosatetraenoic acid release and mast cell/eosinophil activation in nasal polyps from aspirin-sensitive patients |
| Q36283335 | Lessening the Misery of Nasal Polyps: Keeping this chronic disease under control |
| Q89358251 | Letter to the Editor: Prognosis and risk in considering extensive vs functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps and asthma |
| Q67325242 | Letter to the editor: Reinvestigation of the normal length of the adult sella turcica with special reference to nasal polyps |
| Q68819278 | Letter: Rhinitis and nasal polyps in asthma |
| Q68483304 | Lipoxin formation in human nasal polyps and bronchial tissue |
| Q102329834 | Local IL-17 positive T cells are functionally associated with neutrophil infiltration and their development is regulated by mucosal microenvironment in nasal polyps |
| Q92431126 | Local fungus-specific Immunoglobulin E production in chronic rhinosinusitis with nasal polyps |
| Q54202786 | Local increase in IgE and class switch recombination to IgE in nasal polyps in chronic rhinosinusitis. |
| Q104287765 | Local inflammatory marker production in Lithuanian patients with chronic rhinosinusitis with nasal polyps |
| Q93642868 | Local specific IgE production in nasal polyps associated with negative skin tests and serum RAST |
| Q58269746 | Localization of Cystic Fibrosis Transmembrane Conductance Regulator in Epithelial Cells of Nasal Polyps and Postoperative Polypoid Mucosae |
| Q102135861 | Long term outcomes of balloon sinuplasty for the treatment of chronic rhinosinusitis with and without nasal polyps |
| Q67836411 | Long term study of aerosol corticosteroid treatment (Syntaris) in nasal polyps |
| Q92431121 | Long-term outcomes of different endoscopic sinus surgery in recurrent chronic rhinosinusitis with nasal polyps and asthma |
| Q40888425 | Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. I. Treatment and rationale |
| Q39585209 | Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. II. Clinical results |
| Q43807083 | Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. III. Morphological studies and conclusions |
| Q60191465 | Low lymphatic vessel density associates with chronic rhinosinusitis with nasal polyps |
| Q47618282 | Lymphocyte subpopulations and cytokines in nasal polyps: is there a local immune system in the nasal polyp? |
| Q72732402 | Lymphocyte subsets and antigen-specific IgE antibody in nasal polyps |
| Q68194548 | Lymphocytes and nonlymphoid cells in human nasal polyps |
| Q93524279 | Lymphocytes and nonlymphoid cells in the nasal mucosa of patients with nasal polyps and of healthy subjects |
| Q47235128 | Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage |
| Q85788976 | Macrophage inflammatory protein-1 production and eosinophil infiltration in chronic rhinosinusitis with nasal polyps |
| Q83479270 | Macroprolactinomas presenting as nasal polyps: a series of three cases |
| Q71561503 | Magical numbers and the treatment of nasal polyps |
| Q38762452 | Management of Otic and Nasopharyngeal, and Nasal Polyps in Cats and Dogs |
| Q38480302 | Management of chronic rhinosinusitis with nasal polyps and coexisting asthma: A systematic review. |
| Q37814903 | Management of nasal polyps in 'aspirin sensitive asthma' triad |
| Q40372902 | Management of nasal polyps: is objective assessment possible? |
| Q104607445 | Mass cytometry reveals unique subsets of T cells and lymphoid cells in nasal polyps from patients with chronic rhinosinusitis (CRS) |
| Q54241815 | Mast cell quantitation in nasal polyps, sinus mucosa and nasal turbinate mucosa. |
| Q73400156 | Mast cell ultrastructure in the inferior turbinate and stroma of nasal polyps |
| Q80365487 | Matrix metalloproteases in vernal keratoconjunctivitis, nasal polyps and allergic asthma |
| Q81798217 | Matrix metalloproteinase-2 gene polymorphisms in nasal polyps |
| Q82205983 | Matrix metalloproteinase-9 (MMP-9) in allergic nasal polyps |
| Q88086973 | Mechanical disfunction in the mucosal oedema formation of patients with nasal polyps |
| Q59302932 | Mechanisims of asthma and allergic disease – 1082. Relevance of IL-17A to eosinopil accumulation and mucosal remodeling in chronic rhinosinusitis and nasal polyps |
| Q104484175 | Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps |
| Q24243538 | Medical versus surgical interventions for nasal polyps |
| Q46411260 | Melatonin expression in nasal polyps in patients with asthmatic triad |
| Q67268685 | Meningiomas presenting as nasal polyps |
| Q78633379 | Metacortandracin (prednisone) in bronchial asthma: comparative effects of metacortandracin, hydrocortisone, and cortisone in bronchial asthma with diabetes mellitus and bronchial asthma with nasal polyps; preliminary report |
| Q74217093 | Metaplastic bone formation in nasal polyps with histologic presence of transforming growth factor beta-1 (TGFbeta-1) and bone morphogenetic proteins (BMPs) |
| Q38688070 | Methotrexate Induces Apoptosis in Organ-Cultured Nasal Polyps Via the Fas Pathway |
| Q42712947 | Methotrexate induces apoptosis in nasal polyps via caspase cascades and both mitochondria-mediated and p38 mitogen-activated protein kinases/Jun N-terminal kinase pathways |
| Q88235818 | Micro124-mediated AHR expression regulates the inflammatory response of chronic rhinosinusitis (CRS) with nasal polyps |
| Q58088228 | MicroRNAs regulating mucin type O-glycan biosynthesis and transforming growth factor β signaling pathways in nasal mucosa of patients with chronic rhinosinusitis with nasal polyps in Northern China |
| Q30437324 | Microarray analysis of distinct gene transcription profiles in non-eosinophilic chronic sinusitis with nasal polyps |
| Q98564991 | Microarray analysis of primary epithelial and fibroblast cells in chronic rhinosinusitis without nasal polyps |
| Q84482771 | Microarray gene analysis of Toll-like receptor signaling elements in chronic rhinosinusitis with nasal polyps |
| Q67836415 | Microbiological and cytological analysis of patients with nasal polyps |
| Q89662516 | Minimally invasive surgery under local anaesthesia for chronic rhinosinusitis with nasal polyps: our experience in older adults |
| Q37165624 | Modulators of ion transport in nasal polyps: an in situ measurement of short-circuit current |
| Q46789294 | Montelukast: new therapeutic option in patients with nasal polyps associated to respiratory allergic disease |
| Q70418341 | Morphological changes in nasal polyps during their incubation with serotonin liberators (development cycle of mast cell-serotoninocytes) |
| Q58278275 | Mucin gene expression in nasal polyps |
| Q71721587 | Mucociliary function in patients with nasal polyps |
| Q85080226 | Mucosal eosinophilia and recurrence of nasal polyps - new classification of chronic rhinosinusitis |
| Q68725304 | Mucous nasal polyps can be managed non-surgically |
| Q58280247 | Mucoviscidosis and Nasal Polyps |
| Q70817062 | Multifactorial etiology of nasal polyps |
| Q100461128 | Multiparametric Analysis of Factors Associated With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps |
| Q41089845 | Multiple polysomies in nasal polyps in children |
| Q42444721 | Multiplex analyses of cytokine and chemokine release from the cultured fibroblast of nasal polyps: the effect of IL-17A. |
| Q73497610 | Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps |
| Q76508240 | NASAL POLYPS AND CYSTIC FIBROSIS OF THE PANCREAS |
| Q40976137 | NASAL POLYPS FROM A DEVELOPMENTAL POINT OF VIEW |
| Q93376637 | NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps |
| Q62661926 | Narrow-band UVB phototherapy of nasal polyps: Results of a pilot study |
| Q50033970 | Nasal IL-25 predicts the response to oral-corticosteroid in chronic rhinosinusitis with nasal polyps (CRSwNP). |
| Q92661616 | Nasal Nitric Oxide in Chronic Rhinosinusitis with or without Nasal Polyps: A Systematic Review with Meta-Analysis |
| Q50087546 | Nasal Polyps and Biomarkers |
| Q92652383 | Nasal Polyps and Chronic Obstructive Pulmonary Disease-An Oft Overlooked Association |
| Q92250617 | Nasal Polyps, Multifocal Laryngeal Masses, and Subglottic Stenosis in a Middle-aged Man |
| Q80731437 | Nasal conditioning after endonasal surgery in chronic rhinosinusitis with nasal polyps |
| Q80137347 | Nasal contact endoscopy for the in vivo diagnosis of inverted schneiderian papilloma and unilateral inflammatory nasal polyps |
| Q69037924 | Nasal disorders in children. Allergic rhinitis, vasomotor rhinitis, and nasal polyps |
| Q91596798 | Nasal fluid cytology and cytokine profiles of eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps |
| Q47859198 | Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study. |
| Q96116975 | Nasal nebulization inhalation of budesonide for chronic rhinosinusitis with nasal polyps: A protocol for systematic review and meta-analysis |
| Q73092886 | Nasal polyposis: immunohistochemistry and bioelectrical findings (a hypothesis for the development of nasal polyps) |
| Q30461799 | Nasal polyps - histopathologic spectrum |
| Q67539600 | Nasal polyps and bronchial asthma |
| Q67382258 | Nasal polyps and disposition to the development of asthma |
| Q91671605 | Nasal polyps and future risk of head and neck cancer: A nationwide population-based cohort study |
| Q41216858 | Nasal polyps and immunoglobulin E (IgE). |
| Q42456357 | Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B. |
| Q91128327 | Nasal polyps and rhinosinusitis |
| Q72796325 | Nasal polyps and sinusitis |
| Q73937348 | Nasal polyps and sinusitis |
| Q45493503 | Nasal polyps and sinusitis in children with cystic fibrosis. |
| Q34385143 | Nasal polyps and sinusitis. |
| Q79769661 | Nasal polyps and the severity of asthma |
| Q44995573 | Nasal polyps and their content of arachidonic acid metabolites |
| Q74348861 | Nasal polyps and their relation to polyps/hypertrophic polypoid mucosa in the paranasal sinuses: a macro-, endo-, and microscopic study of autopsy materials |
| Q70926170 | Nasal polyps as a side-effect in the use of beta blockaders |
| Q71785792 | Nasal polyps as immunoreactive tissue |
| Q71636400 | Nasal polyps causing bone destruction and blindness |
| Q52613610 | Nasal polyps do not contain olfactory structures. |
| Q53604088 | Nasal polyps herniating through lacrimal-nasal bony ostium mimicking dacryocystocele: a rare cause of DCR failure. |
| Q70950508 | Nasal polyps im maxillary sinus. Report of a case |
| Q67001995 | Nasal polyps in Peutz-Jeghers syndrome |
| Q73145473 | Nasal polyps in a cat |
| Q40826255 | Nasal polyps in asthma and rhinitis. A review of 6,037 patients |
| Q70402256 | Nasal polyps in children |
| Q71274007 | Nasal polyps in children |
| Q73517621 | Nasal polyps in children |
| Q71693824 | Nasal polyps in children with mucoviscidosis |
| Q44306489 | Nasal polyps in children: a ten year study |
| Q67715854 | Nasal polyps in cystic fibrosis |
| Q50690041 | Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. |
| Q82781215 | Nasal polyps in dogs: five cases (2005 to 2011) |
| Q98563491 | Nasal polyps in eosinophilic granulomatosis with polyangiitis: Structured histopathology and CD105 expression |
| Q67993760 | Nasal polyps in identical twins |
| Q46442609 | Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators |
| Q26752819 | Nasal polyps in patients with asthma: prevalence, impact, and management challenges |
| Q51710180 | Nasal polyps in patients with rhinitis and asthma. |
| Q74150966 | Nasal polyps in relation to nasal sinusitis |
| Q77102666 | Nasal polyps in the olfactory cleft |
| Q38081447 | Nasal polyps in the pediatric population. |
| Q28193972 | Nasal polyps is not a homogenous pathology |
| Q73409534 | Nasal polyps masking a unilateral choanal atresia |
| Q74488348 | Nasal polyps removed for histological examination |
| Q79280980 | Nasal polyps surgery in children |
| Q40823361 | Nasal polyps treated by beclomethasone nasal aerosol |
| Q41216875 | Nasal polyps treatment: medical management |
| Q41216806 | Nasal polyps update. Histopathology |
| Q71003697 | Nasal polyps with atypical stroma cells: a pseudosarcomatous lesion. A light and electron-microscopic and immunohistochemical investigation with implications on the type and nature of the mesenchymal cells |
| Q33662196 | Nasal polyps with metaplastic ossification: CT and MR imaging findings |
| Q98946500 | Nasal polyps with osseous metaplasia: A misunderstood situation |
| Q46581534 | Nasal polyps, aspirin sensitivity, and late onset asthma are crucial to identify severe asthma. clinicaltrials.gov id : nct01513837. |
| Q36007625 | Nasal polyps, bronchial asthma and aspirin sensitivity |
| Q93595208 | Nasal polyps, bronchial asthma, and aspirin sensitivity: the Samter syndrome |
| Q50941568 | Nasal polyps, nasal polypectomy, asthma, and aspirin sensitivity. Their association in 445 cases of nasal polyps. |
| Q43671479 | Nasal polyps, syncope, and asthma |
| Q53442102 | Nasal polyps: An independent risk factor for bronchial hyperresponsiveness in patients with allergic rhinitis. |
| Q36256956 | Nasal polyps: a clinical, histopathological and radiological profile |
| Q36620969 | Nasal polyps: a comparative study of morphologic and etiopathogenetic aspects. |
| Q69256958 | Nasal polyps: a manifestation of allergy? |
| Q50949192 | Nasal polyps: a predisposing factor for cutaneous leishmaniasis of the lips? |
| Q43787007 | Nasal polyps: a sign of disease |
| Q84551514 | Nasal polyps: an update |
| Q54212371 | Nasal polyps: effects of seasonal allergen exposure. |
| Q69409915 | Nasal polyps: epithelium and goblet cell density |
| Q83389160 | Nasal polyps: heredity, allergies, and environmental and occupational exposure |
| Q71335986 | Nasal polyps: medical or surgical management? |
| Q53651022 | Nasal polyps: not always an ENT problem. |
| Q37881272 | Nasal polyps: pathogenesis and treatment implications |
| Q41216826 | Nasal polyps: relationship to infection and inflammation. |
| Q28194960 | Nasal polyps: still more questions than answers |
| Q80023347 | Nasal polyps: the relationship to allergy, sinonasal infection and histopathological type |
| Q77155478 | Nasal polyps: their relationship to allergy, particularly to bronchial asthma |
| Q77930614 | Nasal polyps: treat or refer? |
| Q73822753 | Nasal polyps; causes of recurrence and its effective control |
| Q46781038 | Naso-sinusienne sarcoidosis |
| Q38747812 | Neuronal Differentiation Capability of Nasal Polyps of Chronic Rhinosinusitis |
| Q100949786 | Neutrophil infiltrates and eosinophil aggregates in chronic rhinosinusitis with nasal polyps and EGPA |
| Q70412205 | New bone formation in nasal polyps |
| Q90578014 | Non-Eosinophilic Chronic Rhinosinusitis With Nasal Polyps: Eosinophil, Basophil, and Neutrophil Blood Counts Before and After Surgery |
| Q35800401 | Non-Eosinophilic Nasal Polyps Shows Increased Epithelial Proliferation and Localized Disease Pattern in the Early Stage |
| Q37741477 | Non-surgical management of chronic rhinosinusitis with nasal polyps based on clinical-cytological grading: a precision medicine-based approach. |
| Q93371421 | Noninvasive exosomal proteomic biosignatures, including cystatin SN, peroxiredoxin-5, and glycoprotein VI, accurately predict chronic rhinosinusitis with nasal polyps |
| Q71537774 | Noradrenergic innervation of nasal polyps and polypoid mucosae |
| Q72484773 | Normalization of maxillary sinus mucosa after FESS. A prospective study of chronic sinusitis with nasal polyps |
| Q91801953 | Notch-1 signaling activation sustains overexpression of interleukin 33 in the epithelium of nasal polyps |
| Q90090334 | Novel roles for nasal epithelium in the pathogenesis of chronic rhinosinusitis with nasal polyps |
| Q96963974 | Nuclear Factor κB/MicroRNA-155 Upregulates the Expression Pattern of Cytokines in Regulating the Relapse of Chronic Sinusitis with Nasal Polyps and the Underlying Mechanism of Glucocorticoid |
| Q28195310 | Nuclear factor-kappaB activity is down-regulated in nasal polyps from aspirin-sensitive asthmatics |
| Q91927125 | Objective and subjective changes in voice after endoscopic sinus surgeries in patients with and without nasal polyps |
| Q90956612 | Obstructive sleep apnea in patients with chronic rhinosinusitis with nasal polyps: a cross-sectional study |
| Q33204402 | Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps |
| Q72336020 | Of nasal polyps |
| Q90603605 | Olfactory bulb neuroplasticity: A prospective cohort study in patients with chronic rhinosinusitis with nasal polyps |
| Q91216659 | Olfactory dysfunction in patients with chronic rhinosinusitis with nasal polyps is associated with clinical-cytological grading severity |
| Q49152600 | Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma |
| Q48554595 | Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study |
| Q72684836 | On the clinical peculiarities of nasal polyps with altered epithelium and mucous membrane |
| Q72954386 | On the morphogenesis of nasal polyps |
| Q38034190 | Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations |
| Q38584414 | Oral corticosteroids in the management of chronic rhinosinusitis with and without nasal polyps: Risks and benefits |
| Q24185937 | Oral steroids for nasal polyps |
| Q24235433 | Oral steroids for nasal polyps |
| Q24244457 | Oral steroids for nasal polyps |
| Q24246547 | Oral steroids for nasal polyps |
| Q93113220 | Orchestration of immunoglobulin isotypes, subclasses, and specificities in patients receiving intravenous IgG or subcutaneous immunotherapy and those with chronic rhinosinusitis with nasal polyps: Toward precision medicine |
| Q79872161 | Origin of nasal polyps: an endoscopic autopsy study |
| Q84858566 | Osteitis in chronic rhinosinusitis with nasal polyps: a comparative study between primary and recurrent cases |
| Q90405100 | Osteitis is associated with dysregulated pro-osteoblastic activity in patients with nasal polyps |
| Q28165524 | Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma |
| Q73593049 | Overexpression of Fas-ligand in human nasal polyps |
| Q90855263 | Overexpression of hypoxia-inducible factor 1α is associated with neutrophilic inflammation in chronic rhinosinusitis with nasal polyps |
| Q82446290 | Overexpression of miR-125b, a novel regulator of innate immunity, in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q67977920 | Oxidative metabolism of N-phenyllinoleamide by human nasal polyps |
| Q79142226 | Oxidative stress in nonallergic nasal polyps associated with bronchial hyperresponsiveness |
| Q87406880 | P-glycoprotein promotes epithelial T helper 2-associated cytokine secretion in chronic sinusitis with nasal polyps |
| Q74522550 | PCR analysis of nasal polyps, chronic sinusitis, and hypertrophied turbinates for DNA encoding bacterial 16S rRNA |
| Q39171019 | Paediatric nasal polyps in cystic fibrosis. |
| Q41776382 | Pathogenesis and therapy of nasal polyps |
| Q90626567 | Pathogenesis of chronic rhinosinusitis with nasal polyps: role of IL-6 in airway epithelial cell dysfunction |
| Q67703248 | Pathogenesis of nasal polyps |
| Q28192544 | Pathogenesis of nasal polyps: an update |
| Q67345376 | Pathomechanism of nasal polyps |
| Q36005789 | Pathophysiological effects of glucocorticoids on nasal polyps: an update. |
| Q49074250 | Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China |
| Q91429635 | Patterns, Presentations and Prognosis of Nasal Polyps |
| Q47640134 | Periostin as a Biomarker for Nasal Polyps in Chronic Rhinosinusitis |
| Q44284287 | Periostin may play a protective role in the development of eosinophilic chronic rhinosinusitis with nasal polyps in a mouse model |
| Q84288577 | Peroxisome proliferator-activated receptor-γ is expressed in eosinophils in nasal polyps |
| Q71971399 | Peutz-Jeghers syndrome |
| Q58099060 | Phosphoinositide 3-kinase-delta could be a biomarker for eosinophilic nasal polyps |
| Q50936786 | Phospholipase A2-dependent release of inflammatory cytokines by superantigen-stimulated nasal polyps of patients with chronic rhinosinusitis. |
| Q71080165 | Physiopathology of nasal polyps. Are nasal polyps of allergic origin? |
| Q74415881 | Plasminogen activators in human nasal polyps and mucosa |
| Q28288597 | Polymorphism between loci for human leukocyte antigens DR and DQ in patients with nasal polyps |
| Q39235702 | Polymorphisms in chronic rhinosinusitis with nasal polyps - a systematic review. |
| Q36471854 | Polyp in concha bullosa: a case report and review of the literature |
| Q89284118 | Polypoid change of middle turbinate is associated to an increased risk of polyp recurrence after surgery in patients with chronic rhinosinusitis with nasal polyps |
| Q34118286 | Possible role of EMID2 on nasal polyps pathogenesis in Korean asthma patients |
| Q91064828 | Postoperative Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: Impact of High-Dose Corticosteroid Nasal Spray |
| Q44432091 | Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis |
| Q99413702 | Predictive Significance of Charcot-Leyden Crystal Protein in Nasal Secretions in Recurrent Chronic Rhinosinusitis with Nasal Polyps |
| Q91589071 | Predictive Significance of Charcot-Leyden Crystals for Eosinophilic Chronic Rhinosinusitis With Nasal Polyps |
| Q97636064 | Predictive and Diagnostic Value of Nasal Nitric Oxide in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps |
| Q91284674 | Predictive markers of long-term recurrence in chronic rhinosinusitis with nasal polyps |
| Q99711669 | Predictive significance of arachidonate 15-lipoxygenase for eosinophilic chronic rhinosinusitis with nasal polyps |
| Q93014344 | Predictive value of computed tomography in the recurrence of chronic rhinosinusitis with nasal polyps |
| Q90687484 | Predictors of efficacy for combination oral and topical corticosteroids to treat patients with chronic rhinosinusitis with nasal polyps |
| Q79076745 | Preliminary study of correlation factor in surgery effect of nasal polyps |
| Q98726917 | Preoperative Pulmonary Function Testing to Predict Recurrence of Chronic Rhinosinusitis With Nasal Polyps |
| Q49091088 | Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma |
| Q58274021 | Presence of Neuropeptides in Human Nasal Polyps |
| Q86048680 | Presence of hyaluronidase isoforms in nasal polyps |
| Q28194706 | Presence of platelet-activating factor in nasal polyps and eosinophils |
| Q28199852 | Present opinions on treatment of nasal polyps |
| Q44992407 | Prevalence and abundance of Staphylococcus aureus in the middle meatus of patients with chronic rhinosinusitis, nasal polyps, and asthma |
| Q80919697 | Prevalence of Helicobacter pylori in patients with nasal polyps: a preliminary report |
| Q41580602 | Prevalence of nasal polyps and its risk factors: Korean National Health and Nutrition Examination Survey 2009-2011. |
| Q86196505 | Prevalence of nasal polyps in Northern Portugal: a cadaver endoscopic study |
| Q28198686 | Prevalence of nasal polyps in adults: the Skövde population-based study |
| Q91450786 | Pro-inflammatory role of transient receptor potential canonical channel 6 in the pathogenesis of chronic rhinosinusitis with nasal polyps |
| Q42119664 | Proctocolitis induced by salicylate and associated with asthma and recurrent nasal polyps |
| Q86977723 | Profiling the immunological characteristics of exacerbation of chronic rhinosinusitis with nasal polyps |
| Q90972286 | Prognosis of Chronic Rhinosinusitis With Nasal Polyps Using Preoperative Eosinophil/Basophil Levels and Treatment Compliance |
| Q92629405 | Prognostic Significance of Serum Complement Component 3 in Chronic Rhinosinusitis with Nasal Polyps |
| Q38700275 | Prognostic value of nasal cytology and clinical factors in nasal polyps development in patients at risk: can the beginning predict the end? |
| Q87117594 | Prolidase activity and oxidative stress parameters in patients with nasal polyps |
| Q30410446 | Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease |
| Q90116639 | Prospective evaluation of clarithromycin in recurrent chronic rhinosinusitis with nasal polyps |
| Q34434995 | Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity. |
| Q70162596 | Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa |
| Q45985659 | Protein microarray analysis of nasal polyps from aspirin-sensitive and aspirin-tolerant patients with chronic rhinosinusitis. |
| Q78746354 | Protein pattern in polyp fluid and cellular infiltration of nasal polyps |
| Q89709160 | Proteomics profiling of epithelium-derived exosomes from nasal polyps revealed signaling functions affecting cellular proliferation |
| Q38742008 | Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase |
| Q70750659 | Quantification of interleukin-1 in nasal polyps from patients with chronic sinusitis |
| Q83028556 | Quantification of the mRNA encoding Tumor Necrosis Factor alpha (TNFalpha) and its receptors in human nasal polyps |
| Q72493210 | Quantitation and immunocytological identification of interleukin-1 in nasal polyps from patients with chronic sinusitis |
| Q74170972 | Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils |
| Q78147422 | Quantitative glycohistochemical characterization of normal nasal mucosa, and of single as opposed to massive nasal polyps |
| Q54542900 | RKIP and BRAF aberrations in human nasal polyps and the adjacent turbinate mucosae. |
| Q76961677 | ROLE OF ALLERGY AND RADIATION IN THE MANAGEMENT OF NASAL POLYPS |
| Q74435874 | Radical pansinus operations in cases of nasal polyps; a follow-up study |
| Q48677706 | Radiofrequency-induced thermotherapy on nasal polyps: preliminary results |
| Q71769013 | Radiological changes associated with benign nasal polyps |
| Q96017166 | Randomized clinical trial to evaluate mometasone lavage vs spray for patients with chronic rhinosinusitis without nasal polyps who have not undergone sinus surgery |
| Q100515698 | Rapid effect of benralizumab for severe asthma with chronic rhinosinusitis with nasal polyps |
| Q43938165 | Real-time PCR detection of Helicobacter pylori and virulence-associated cagA in nasal polyps and laryngeal disorders |
| Q64239280 | Recovery of smell sense loss by mepolizumab in a patient allergic to Dermatophagoides and affected by chronic rhinosinusitis with nasal polyps |
| Q44140828 | Recurrence of nasal polyps after surgical treatment. |
| Q48071841 | Recurrent nasal polyps as a monosymptomatic form of cystic fibrosis associated with a novel in-frame deletion (591del18) in the CFTR gene |
| Q37766878 | Recurrent nasal polyps treated by Chinese herbal decoction and acupuncture: a case report |
| Q48422094 | Recurrent simple nasal polyps associated with Sheehan's syndrome |
| Q62520456 | Reduced expression of COXs and production of prostaglandin E2 in patients with nasal polyps with or without aspirin-intolerant asthma |
| Q37693108 | Reduced growth and proliferation dynamics of nasal epithelial stem/progenitor cells in nasal polyps in vitro |
| Q46779058 | Regulation of expression of galectin-7 in human nasal polyps by budesonide |
| Q44906352 | Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. |
| Q86904866 | Regulatory effect of TLR3 signaling on staphylococcal enterotoxin-induced IL-5, IL-13, IL-17A and IFN-γ production in chronic rhinosinusitis with nasal polyps |
| Q84796457 | Relationship between Postoperative Recurrence Rate and Eosinophil Density of Nasal Polyps |
| Q84745162 | Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis |
| Q79420261 | Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps |
| Q38616004 | Relative frequencies of symptoms and risk factors among patients with chronic rhinosinusitis with nasal polyps using a case-control study |
| Q37581116 | Release of Type 2 Cytokines by Epithelial Cells of Nasal Polyps |
| Q48123931 | Reply to the letter to the editor concerning: Chronic rhinosinusitis with nasal polyps are associated with chronic otitis media in the elderly. |
| Q33334143 | Research of gene chip detection and gene expression profile of nasal polyps |
| Q91429949 | Respiratory Epithelial Adenomatoid Hamartoma (REAH) in the Olfactory Cleft: Often Masked by Bilateral Nasal Polyps |
| Q42710772 | Resveratrol prevents development of eosinophilic rhinosinusitis with nasal polyps in a mouse model |
| Q91376428 | Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors |
| Q38103708 | Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease |
| Q97526764 | Rhinosinusitis without nasal polyps in COPD |
| Q79188595 | Rhinosporidiosis presenting as recurrent nasal polyps |
| Q92261179 | Role of Amphotericin B in Nasal Irrigation for Chronic Rhinosinusitis with Nasal Polyps |
| Q36214164 | Role of Apoptosis in the Pathogenesis of Nasal Polyps Based Upon Galectin-3 Expression |
| Q86237964 | Role of IFN-γ, IL-13, and IL-17 on mucociliary differentiation of nasal epithelial cells in chronic rhinosinusitis with nasal polyps |
| Q90884836 | Role of RANK-L as a potential inducer of ILC2-mediated type 2 inflammation in chronic rhinosinusitis with nasal polyps |
| Q104267658 | Role of Yes-associated protein in Interleukin-13 induced nasal remodeling of chronic rhinosinusitis with nasal polyps |
| Q52571483 | Role of allergy in nasal polyps of Thai patients. |
| Q51717498 | Role of atopy in chronic rhinosinusitis with nasal polyps: does an atopic condition affect the severity and recurrence of disease? |
| Q91239966 | Role of blood inflammatory cells in chronic rhinosinusitis with nasal polyps |
| Q82256782 | Role of fungal antigens in eosinophilia-associated cellular responses in nasal polyps: a comparison with enterotoxin |
| Q51038042 | Role of interferon-γ-producing t cells in the pathogenesis of chronic rhinosinusitis with nasal polyps associated with staphylococcal superantigen |
| Q84388574 | Role of interleukin-17A in the eosinophil accumulation and mucosal remodeling in chronic rhinosinusitis with nasal polyps associated with asthma |
| Q92430177 | Role of the TAp63 Isoform in Recurrent Nasal Polyps |
| Q86446502 | Role of the aryl hydrocarbon receptor in the pathogenesis of chronic rhinosinusitis with nasal polyps |
| Q34647395 | Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children |
| Q84592392 | Samter's triad and eicosanoid imbalance in children with recurrent nasal polyps |
| Q73044508 | Sarcoidosis presenting as recurrent nasal polyps |
| Q72375117 | Search for the human papillomavirus in nasal polyps, using a polymerase chain reaction-method |
| Q51103579 | Selective expansion of human regulatory T cells in nasal polyps, and not adjacent tissue microenvironments, in individual patients exposed to steroids. |
| Q43904182 | Sensitivity of a new grading system for studying nasal polyps with the potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide). |
| Q69584241 | Sensitivity to non-acetylated salicylates in a patient with asthma, nasal polyps, and rheumatoid arthritis |
| Q75994690 | Serologic investigations on the edema fluid from nasal polyps; a preliminary report |
| Q44696451 | Serotonin in the blood and polypous tissue in patients with nasal polyps |
| Q71631411 | Serotonin-forming capacity of nasal polyps. Effect of the chemical serotonin liberators--reserpine and substance 48-80--on the liberation and synthesis of serotonin in nasal polyps (in vitro) |
| Q98227858 | Serum eosinophil cationic protein: a prognostic factor for early postoperative recurrence of nasal polyps |
| Q96134734 | Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps |
| Q89059428 | Sex difference in counts of α4 and α7 nicotinic acetylcholine receptors in the nasal polyps of adults with or without exposure to tobacco smoke |
| Q37273580 | Sheldon Memorial Lecture. Medical management of nasal polyps and sinusitis |
| Q108542866 | Short Term Pre-Operative Oral Corticosteroids-Tissue Remodeling in Chronic Rhinosinusitis with Nasal Polyps |
| Q84279494 | Short-term antibiotics treatment in patients with nasal polyps and enterotoxins producing Staphylococcus aureus strains |
| Q80919692 | Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes |
| Q81921697 | Significance of nasal polyps in chronic rhinosinusitis: symptoms and surgical outcomes |
| Q92598216 | Significant polyomic and functional upregulation of the PAPP-A/IGFBP-4/5/IGF-1 axis in chronic rhinosinusitis with nasal polyps |
| Q83537952 | Similar cellular proliferation activities in nasal polyps and adjacent inferior turbinate |
| Q67342726 | Simple nasal polyps and allergic manifestations |
| Q84574706 | Sinonasal angiosarcoma? Not likely (a brief description of infarcted nasal polyps) |
| Q37162102 | Sinonasal outcomes after endoscopic sinus surgery in asthmatic patients with nasal polyps: a difference between aspirin-tolerant and aspirin-induced asthma? |
| Q53998873 | Site of origin of nasal polyps. Transcranially removed naso-ethmoidal blocks as a screening method for nasal polyps in autopsy material. |
| Q81338523 | Site of origin of nasal polyps: relevance to pathogenesis and management |
| Q86068892 | Smoking is an independent association of squamous metaplasia in Chinese nasal polyps |
| Q88615364 | Solitary chemosensory cells producing interleukin-25 and group-2 innate lymphoid cells are enriched in chronic rhinosinusitis with nasal polyps |
| Q71750506 | Some immunological parameters in serum and nasal secretion in subjects with vasomotor and allergic rhinitis and nasal polyps - a comparative study |
| Q39919365 | Specific Induction of TSLP by the Viral RNA Analogue Poly(I:C) in Primary Epithelial Cells Derived from Nasal Polyps |
| Q28210335 | Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma |
| Q96648367 | Squamous Cell Carcinoma In Situ Originating From Nasal Polyps With Human Papillomavirus 51 Infection: A Case Report |
| Q88003627 | Staphylococcus aureus enhances the tight junction barrier integrity in healthy nasal tissue, but not in nasal polyps |
| Q89209561 | Staphylococcus aureus impairs sinonasal epithelial repair: Effects in patients with chronic rhinosinusitis with nasal polyps and control subjects |
| Q85228761 | Staphylococcus aureus increases cytokine and matrix metalloproteinase expression in nasal mucosae of patients with chronic rhinosinusitis and nasal polyps |
| Q93121036 | Staphylococcus aureus internalization in mast cells in nasal polyps: Characterization of interactions and potential mechanisms |
| Q35113564 | Staphylococcus aureus superantigens are associated with chronic rhinosinusitis with nasal polyps: a meta-analysis |
| Q90353519 | Staphylococcus aureus, epithelial disruption, and nasal polyps: Are we one step ahead in combatting this foe? |
| Q58106419 | Strategies for composite estimands in confirmatory clinical trials: Examples from trials in nasal polyps and steroid reduction |
| Q100458417 | Stromal cells and B cells orchestrate ectopic lymphoid tissue formation in nasal polyps |
| Q67541868 | Studies on the function of mast cells infiltrating in nasal polyps |
| Q101136584 | Subepithelial neutrophil infiltration as a predictor of the surgical outcome of chronic rhinosinusitis with nasal polyps |
| Q92216987 | Subsetting reveals CD16high CD62Ldim neutrophils in chronic rhinosinusitis with nasal polyps |
| Q83491451 | Summaries for patients: Initial treatment with oral steroids for chronic sinusitis accompanied by nasal polyps |
| Q84502497 | Superantigen-induced glucocorticoid insensitivity in the recurrence of chronic rhinosinusitis with nasal polyps |
| Q92975233 | Superantigen-related TH2 CD4+ T cells in nonasthmatic chronic rhinosinusitis with nasal polyps |
| Q80219609 | Superantigens and chronic rhinosinusitis II: analysis of T-cell receptor V beta domains in nasal polyps |
| Q61442727 | Suppression of Inflammatory Cytokine Secretion by an NF-?B Inhibitor DHMEQ in Nasal Polyps Fibroblasts |
| Q24187909 | Surgical interventions for chronic rhinosinusitis with nasal polyps |
| Q24243674 | Surgical interventions for nasal polyps |
| Q33708513 | Surgical treatment of nasal polyps: past, present, and future |
| Q58082817 | Surgical versus Medical Treatment of Nasal Polyps |
| Q24187493 | Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps |
| Q38594062 | Surgical versus medical interventions in CRS and nasal polyps: comparative evidence between medical and surgical efficacy |
| Q68282196 | Sweat sodium levels in adults with nasal polyps |
| Q69011097 | Sweat sodium levels in adults with nasal polyps |
| Q90624945 | Symptom Control of Patients With Chronic Rhinosinusitis With Nasal Polyps Under Maintenance Therapy With Daily Acetylsalicylic Acid |
| Q24185939 | Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults |
| Q24234623 | Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults |
| Q49093882 | Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease |
| Q43475763 | Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients |
| Q94539299 | T helper 2 inflammatory markers are associated with recurrence in chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery |
| Q81552387 | T helper cell population and eosinophilia in nasal polyps |
| Q54113359 | T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed TH1/TH2 pattern of cytokines. |
| Q36301719 | T-cell phenotypes in chronic rhinosinusitis with nasal polyps in Japanese patients |
| Q80551100 | TGF-beta 1 downregulates CFTR expression and function in nasal polyps of non-CF patients |
| Q93077275 | TGF-β1 Induces Epithelial-Mesenchymal Transition of Chronic Sinusitis with Nasal Polyps through MicroRNA-21 |
| Q88666577 | TIM-3-Expressing Mast Cells Are Present in Chronic Rhinosinusitis with Nasal Polyps |
| Q89366813 | TREM-1 Neutrophil Activation Pathway Is Suppressed in Eosinophilic Nasal Polyps |
| Q57163486 | Temporary olfactory improvement in chronic rhinosinusitis with nasal polyps after treatment |
| Q88868764 | Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps |
| Q90368803 | Th2 inflammatory responses in the development of nasal polyps and chronic rhinosinusitis |
| Q101227652 | The Clinical and Radiological Characterizations of the Allergic Phenotype of Chronic Rhinosinusitis with Nasal Polyps |
| Q102329301 | The Effect of Dupilumab on Intractable Chronic Rhinosinusitis with Nasal Polyps in Japan |
| Q95318965 | The Effect of Vidian Neurectomy on Pulmonary Function in Patients with Allergic Rhinitis and Chronic Rhinosinusitis with Nasal Polyps |
| Q34389633 | The Epidemiological and Clinical Aspects of Nasal Polyps that Require Surgery |
| Q47802396 | The European positional paper on rhinosinusitis and nasal polyps: has the introduction of guidance on the management of sinus disease affected uptake of surgery and acute admissions for sinusitis? |
| Q91985952 | The GALEN rhinosinusitis cohort: chronic rhinosinusitis with nasal polyps affects health-related quality of life |
| Q89132622 | The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps |
| Q92077377 | The IL-37-Mex3B-Toll-like receptor 3 axis in epithelial cells in patients with eosinophilic chronic rhinosinusitis with nasal polyps |
| Q100508683 | The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps |
| Q102331747 | The Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps |
| Q91826601 | The Role of Biologics in the Treatment of Nasal Polyps |
| Q90270949 | The Role of NF-κB in Chronic Rhinosinusitis With Nasal Polyps |
| Q90083876 | The Role of Relaxin-2 in Tissue Remodeling of Chronic Rhinosinusitis With Nasal Polyps |
| Q96768778 | The Treatment Paradigm of Chronic Rhinosinusitis with Nasal Polyps in the COVD-19 era |
| Q54141345 | The acid mucopolysaccharide and collagen content of human nasal polyps, human and animal nasal mucosa. |
| Q41964438 | The activity of N-acetyl-β-d-hexosaminidase A and B and β-glucuronidase in nasal polyps and hypertrophic nasal concha |
| Q50268768 | The agony of nasal polyps and the terror of their removal 200 years ago: one surgeon's description |
| Q28195858 | The analysis of RCAS1 and DFF-45 expression in nasal polyps with respect to immune cells infiltration. |
| Q38176318 | The association between allergy and chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations |
| Q84109925 | The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polyps |
| Q83363373 | The bacteriology of chronic rhinosinusitis with and without nasal polyps |
| Q46541710 | The change of proliferative potential of fibroblasts derived of nasal polyps in vitro cultured, influenced by derivatives vitamins D |
| Q44052743 | The clinical and laboratory correlates of nasal polyps in cystic fibrosis |
| Q88751297 | The clinical characteristics and histopathological features of chronic rhinosinusitis with unilateral nasal polyps in 136 patients in Southern China |
| Q50991843 | The clinical relationship of nasal polyps to asthma. |
| Q96770357 | The clinical relevance of the clinical cytological grading in patients with chronic rhinosinusitis with nasal polyps |
| Q77956298 | The cystic fibrosis conductance regulator gene exon sequence is normal in a patient with edematous eosinophilic nasal polyps |
| Q71561545 | The detection of Mycoplasma pneumoniae in nasal polyps |
| Q71698172 | The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps |
| Q46442685 | The effect of high-dose topical corticosteroid therapy on prevention of recurrent nasal polyps after revision endoscopic sinus surgery |
| Q72131191 | The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy |
| Q79205459 | The effects of intranasal FP on the expression of aquaporin-2 in nasal polyps |
| Q57057642 | The effects of systemic steroid therapy on macrophage migration inhibitory factor concentrations in patients with nasal polyps |
| Q84067795 | The effects of systemic, topical, and intralesional steroid treatments on apoptosis level of nasal polyps |
| Q92971465 | The epithelium-derived inflammatory mediators of chronic rhinosinusitis with nasal polyps |
| Q77891126 | The estimated incidence of symptomatic nasal polyps |
| Q33538899 | The evaluation of metallothionein expression in nasal polyps with respect to immune cell presence and activity. |
| Q85053968 | The expression of TSLP receptor in chronic rhinosinusitis with and without nasal polyps |
| Q49063031 | The expression of dendritic cell subsets in severe chronic rhinosinusitis with nasal polyps is altered |
| Q58604081 | The hippo pathway effector YAP promotes epithelial proliferation and remodeling in chronic rhinosinusitis with nasal polyps |
| Q93814673 | The immunoglobulin content of nasal polyps: immunofluoroscopic localization and immunochemical characterization |
| Q44257988 | The increased number of epithelial mast cells in nasal polyps and adjacent turbinates is not allergy-dependent |
| Q88142065 | The microbiology of chronic rhinosinusitis with and without nasal polyps |
| Q67348583 | The nasal mucosa during long-term treatment with beclomethasone dipropionate aerosol. A light-and scanning electron microscopic study of nasal polyps |
| Q35098348 | The nasal polyps as a tool for basic research in cystic fibrosis. |
| Q72831283 | The nasal reactivity in patients with nasal polyps |
| Q83279221 | The pathology of nasal polyps |
| Q79535530 | The pathology of nasal polyps and related growths |
| Q98949479 | The postoperative outcomes of patients with chronic rhinosinusitis with nasal polyps by sustained released steroid from hyaluronic acid gel |
| Q83816745 | The presence of B7-H4+ macrophages and CD25+CD4+ and FOXP3+ regulatory T cells in the microenvironment of nasal polyps - a preliminary report |
| Q66892162 | The presence of IgE on the surface of lymphocytes in nasal polyps*1 |
| Q77757135 | The presence of atopy does not determine the type of cellular infiltrate in nasal polyps |
| Q42962960 | The prevalence of nasal polyps and the corresponding urinary LTE4 levels in severe compared to mild and moderate asthma. |
| Q73674874 | The prevalence of nasal polyps in adults with cystic fibrosis |
| Q79535489 | The prevention of recurrence of nasal polyps; a comparison of results of the postoperative use of radium and zinc ion transfer |
| Q78818993 | The problem of nasal polyps |
| Q44450395 | The protein expression of Bcl-x1 and Bcl-2 in eosinophils in nasal polyps and the influence of beclomethasone dipropionate on the expression |
| Q93185019 | The ratio of 11β-hydroxysteroid dehydrogenase 1/11β-hydroxysteroid dehydrogenase 2 predicts glucocorticoid response in nasal polyps |
| Q93358500 | The relationship between endoscopic and radiologic findings and olfactory status of patients with chronic rhinosinusitis with nasal polyps before and after the endoscopic sinus surgery |
| Q64949969 | The relationship of nasal polyps and papillomas to cancer. |
| Q33784834 | The relationship of nasal polyps, infection, and inflammation |
| Q41476096 | The relevance of counseling in patients with nasal polyps |
| Q70576645 | The replication of influenza A viruses in organ cultures of human nasal polyps |
| Q58079651 | The role of ADAM-like decysin 1 in non-eosinophilic chronic rhinosinusitis with nasal polyps |
| Q53525180 | The role of MMP-2, MMP-9, and TIMP-1 in the pathogenesis of nasal polyps: Immunohistochemical assessment at eight different levels in the epithelial, subepithelial, and deep layers of the mucosa. |
| Q89302218 | The role of dendritic cells in immune regulation of nasal polyps |
| Q92279199 | The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps |
| Q84986045 | The role of hepatocyte growth factor/c-Met in chronic rhinosinusitis with nasal polyps |
| Q97437779 | The role of preoperative blood eosinophil counts in distinguishing chronic rhinosinusitis with nasal polyps phenotypes |
| Q81071784 | The role of superantigens in chronic rhinosinusitis with nasal polyps |
| Q85197742 | The role of upper and lower airway patency in chronic rhinosinusitis with nasal polyps and asthma |
| Q99607660 | The roles of nasal nitric oxide in diagnosis and endotypes of chronic rhinosinusitis with nasal polyps |
| Q50683539 | The significant expression of TRPV3 in nasal polyps of eosinophilic chronic rhinosinusitis. |
| Q30965014 | The surface of nasal polyps in the scanning electron microscope |
| Q70832454 | The terrible triad--asthma, nasal polyps, and sensitivity to aspirin |
| Q92671735 | The theory of a "staphylococcus superantigen" in chronic rhinosinusitis with nasal polyps: myth or reality? |
| Q28210472 | The ultrastructure of the nasal polyps in patients with and without cystic fibrosis |
| Q26996734 | The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis |
| Q26780136 | The usefulness of routine histopathology of bilateral nasal polyps - a systematic review, meta-analysis, and cost evaluation |
| Q67956247 | The value of medical treatment in nasal polyps |
| Q100378429 | Therapeutic Effects of Intranasal Tofacitinib on Chronic Rhinosinusitis with Nasal Polyps in Mice |
| Q90216711 | Therapeutic Potential of Dupilumab in the Treatment of Chronic Rhinosinusitis with Nasal Polyps: Evidence to Date |
| Q50453541 | Therapeutic effects of intranasal cyclosporine for eosinophilic rhinosinusitis with nasal polyps in a mouse model. |
| Q37138334 | Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis |
| Q91953608 | Tissue and Exosomal Serine Protease Inhibitors Are Significantly Overexpressed in Chronic Rhinosinusitis With Nasal Polyps |
| Q81869603 | Tissue-specific immunoglobulin E in human nasal polyps |
| Q58250629 | Topical Budesonide Treatment Reduces Endothelial Expression of Intercellular Adhesion Molecules (Vascular Cell Adhesion Molecule-1 and P-selectin) and Eosinophil Infiltration in Nasal Polyps |
| Q44945649 | Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial |
| Q83164854 | Topical glucocorticoids downregulate COX-1 positive cells in nasal polyps |
| Q24185940 | Topical steroids for nasal polyps |
| Q24202139 | Topical steroids for nasal polyps |
| Q24245842 | Topical steroids for nasal polyps |
| Q74605200 | Topical treatment of nasal polyps with a beclomethasone dipropionate powder preparation |
| Q46109208 | Total and antigen- (fungi, mites and staphylococcal enterotoxins) specific IgEs in nasal polyps is related to local eosinophilic inflammation |
| Q43570349 | Total and specific IgE in nasal polyps is related to local eosinophilic inflammation |
| Q58025901 | Trace elements in nasal polyps |
| Q81099332 | Trace elements in nasal polyps |
| Q58150474 | Tracing Human Papillomavirus DNA in Nasal Polyps by Polymerase Chain Reaction |
| Q47306516 | Transcription and translation of the chemokines RANTES and MCP-1 in nasal polyps and mucosa in allergic and non-allergic rhinopathies |
| Q92051342 | Transcription factors gene expression in chronic rhinosinusitis with and without nasal polyps |
| Q91674432 | Translating transcription: proteomics in chronic rhinosinusitis with nasal polyps reveals significant discordance with messenger RNA expression |
| Q83355968 | Transposition of viscera, bronchiectasis and nasal polyps; a genetical analysis and a contribution to the problem of constitution |
| Q92336531 | Treatable traits in chronic rhinosinusitis with nasal polyps |
| Q39561739 | Treatment and prognosis of nasal polyps in cystic fibrosis. |
| Q45153700 | Treatment of nasal polyps |
| Q66896434 | Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol |
| Q101120005 | Tuft cells in the pathogenesis of chronic rhinosinusitis with nasal polyps and asthma |
| Q47988937 | Two inflammatory phenotypes of nasal polyps and comorbid asthma |
| Q94952979 | Type 2 Inflammation in Chronic Rhinosinusitis without Nasal Polyps: Another Relevant Endotype |
| Q53408332 | UBE3C genetic variations as potent markers of nasal polyps in Korean asthma patients. |
| Q78306601 | USE OF ROENTGEN THERAPY IN PREVENTION OF RECURRENCES OF NASAL POLYPS IN THE PREOPERATIVE AND POSTOPERATIVE PERIODS |
| Q72776952 | Ultrastructural and Functional Studies of Cilia from Patients with Asthma, Aspirin Intolerance, and Nasal Polyps |
| Q68115633 | Ultrastructural findings of capillaries in nasal polyps |
| Q43833779 | Ultrastructure of the stroma of nasal polyps: cilia in stromal fibroblasts |
| Q62661897 | Ultraviolet light and photodynamic therapy induce apoptosis in nasal polyps |
| Q94599739 | Understanding the Patient Experience of Severe, Recurrent, Bilateral Nasal Polyps: A Qualitative Interview Study in the United States and Germany |
| Q91340750 | Understanding the Role of Neutrophils in Refractoriness of Chronic Rhinosinusitis With Nasal Polyps |
| Q51828968 | United airways again: high prevalence of rhinosinusitis and nasal polyps in bronchiectasis. |
| Q49022576 | United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient's quality of life. |
| Q72346593 | Unusual nasal polyps |
| Q36414651 | Update on nasal polyps: etiopathogenesis. |
| Q92645870 | Upregulated TRPC5 plays an important role in development of nasal polyps by activating eosinophilic inflammation and NF-κB signaling pathways |
| Q38058474 | Upregulation of Bcl-2 in nasal polyps from patients with cystic fibrosis. |
| Q36184104 | Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis |
| Q64086151 | Upregulation of FZD5 in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps by Epigenetic Modification |
| Q53667558 | Upregulation of MUC8 and downregulation of MUC5AC by inflammatory mediators in human nasal polyps and cultured nasal epithelium. |
| Q83354476 | Upregulation of RANTES in nasal polyps from patients with cystic fibrosis |
| Q87867424 | Upregulation of extraneuronal TRPV1 expression in chronic rhinosinusitis with nasal polyps |
| Q91977717 | Use of biologics in chronic sinusitis with nasal polyps |
| Q44991361 | Various aspects of nasal polyps |
| Q71889603 | Various viewpoints on the etiology, diagnosis and the possibilities of treatment of nasal polyps |
| Q58273404 | Vascular Permeability Factor/Vascular Endothelial Growth Factor in Nasal Polyps |
| Q80304013 | Vascular endothelial growth factor and children featuring nasal polyps |
| Q39638757 | Vascular endothelial growth factor expression in nasal polyps of aspirin-intolerant patients. |
| Q47898659 | Vascular endothelial growth factor in nasal polyps: a comparison of asthmatic and non-asthmatic patients |
| Q57493492 | Vitamin D deficiency are associated with subjective disease severity in Chinese patients with chronic rhinosinusitis with nasal polyps |
| Q53261571 | Vitamin D3 correlates inversely with systemic dendritic cell numbers and bone erosion in chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. |
| Q37606280 | Vγ1⁺ γδT Cells Are Correlated With Increasing Expression of Eosinophil Cationic Protein and Metalloproteinase-7 in Chronic Rhinosinusitis With Nasal Polyps Inducing the Formation of Edema |
| Q51523056 | What Happens With Untreated Nasal Polyps Over Time? A 13-Year Prospective Study. |
| Q73362851 | What causes nasal polyps, and what can I do to get rid of them? |
| Q92795302 | Whole-transcriptome sequencing reveals heightened inflammation and defective host defence responses in chronic rhinosinusitis with nasal polyps |
| Q67008378 | Woakes' syndrome: The problems of infantile nasal polyps |
| Q84556036 | You're the flight surgeon: allergic fungal sinusitis: nasal polyps with R upper lobe cavitary lesion |
| Q28193166 | Zafirlukast in treatment of nasal polyps in patients with aspirin intolerant bronchial asthma--preliminary report |
| Q44983843 | Zygomycosis presenting as nasal polyps in a healthy child. |
| Q68707374 | [A case of coexistence of ozena and nasal polyps] |
| Q82528511 | [A preliminary study of radionuclide imaging of the nasal lymphatic system in nasal polyps] |
| Q79565057 | [A primary study about the correlation between superantigens produced by Staphylococcus aureus and chronic rhinosinusitis with nasal polyps] |
| Q73878245 | [Adrenergic innervation of nasal polyps and pharyngeal tonsil in children] |
| Q71635806 | [Allergic genesis of nasal polyps] |
| Q95810440 | [Analgesic intolerance and nasal polyps] |
| Q92046268 | [Analysis of factors affecting olfactory disfunctions in patients with chronic rhinosinusitis with nasal polyps] |
| Q83972306 | [Analysis of histopathologic parameters and symptomatology in patients with chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery] |
| Q95360396 | [Analysis of olfactory rehabilitation after endoscopic sinus surgery in patients with chronic sinusitis and nasal polyps] |
| Q69520316 | [Antibody-formation capacity of nasal polyps (in vitro)] |
| Q72617803 | [Apropos of mucous nasal polyps] |
| Q71313175 | [Aspirin intolerance in patients with nasal polyps and bronchial asthma] |
| Q85063431 | [Atopy and other factors influence on frequency appearing of different cytological types of nasal polyps] |
| Q84774446 | [Bacteriology of ethmoidal sinus in chronic rhinosinusitis with and without nasal polyps] |
| Q78831275 | [Cell infiltration in nasal polyps and it's pathological significance] |
| Q72151948 | [Changes in connective tissue metabolism in fibroblasts from nasal polyps] |
| Q73652595 | [Chemokine, cytokine, and adhesion molecule dynamics in the nasal washings of patients with nasal polyps] |
| Q92604106 | [Classification of chronic rhinosinusitis with nasal polyps based on eosinophilic inflammation] |
| Q95517750 | [Clinical analysis of endoscopic sinus surgery on patients with chronic sinusitis with nasal polyps complicated and asthma] |
| Q85914934 | [Clinical analysis of nasal resistance and pulmonary function testing in patients with chronic nasal-sinusitis and nasal polyps] |
| Q69615869 | [Clinical and histological studies of nasal polyps] |
| Q98722748 | [Clinical application of Draf type Ⅲ frontal sinus surgery and pedicled septal mucosal flap in recurrent eosinophilic frontal sinusitis with nasal polyps] |
| Q92053384 | [Clinical characteristics of non-eosinophilic and eosinophilic chronic sinusitis with nasal polyps] |
| Q98461315 | [Clinical significance and expression of periostin in chronic rhinosinusitis with nasal polyps] |
| Q88807872 | [Clinical significance of serum allergen sIgE and peripheral blood EOS in patients with chronic sinusitis with nasal polyps] |
| Q88997484 | [Combined operation on chronic rhinosinusitis with nasal polyps and oboslete posttraumatic deviated nose] |
| Q85864956 | [Comment on the European position paper on rhinosinusitis and nasal polyps 2012] |
| Q82441251 | [Comparative study of three primary culture methods of human epithelial cells of nasal polyps in vitro] |
| Q64361026 | [Comparative study on different methods of detecting eosinophils in nasal polyps] |
| Q73426418 | [Concentration of interleukin-5 and granulocyte-macrophage colony stimulation factor in nasal polyps tissue and its significance] |
| Q98722812 | [Correlation analysis between modified nasal endoscopic score and ELR value and subtype of chronic sinusitis with nasal polyps] |
| Q91162067 | [Correlation analysis of eosinophils in peripheral blood and polyp tissues of patients with chronicrhinosinusitis with nasal polyps] |
| Q95389406 | [Correlation analysis of subjective and objective scoring of chronic rhinosinusitis with nasal polyps] |
| Q92497030 | [Correlation of tissue eosinophil count and modified CT olfactory cleft score and olfactory function in patients with nasal polyps] |
| Q81267314 | [Correlative study of nuclear factor-kappa B subunit p50 activity and IL-4 gamma-IFN expression in nasal polyps] |
| Q67345374 | [Cytologic and histologic examination of nasal polyps] |
| Q53674273 | [Cytological examination of nasal polyps smears]. |
| Q71761361 | [Cytology of nasal polyps] |
| Q78008770 | [Day surgery for patients with nasal polyps] |
| Q79731827 | [Detection of specific IgE of anti-Staphylococcus aureus enterotoxins in nasal polyps and analysis theoretically about the superantigen hypothesis] |
| Q71694214 | [Detection of the G551D mutation in a patient with nasal polyps] |
| Q33246005 | [Determination of differentially expressed proteins and it's significance among chronic sinusitis, nasal polyps and normal nasal mucosa]. |
| Q79937666 | [Diagnostic and treatment in nasal polyps of children treated in Wrocław ENT department in the years 1991-2001] |
| Q90493969 | [Different phenotypes in patients with chronic sinusitis with bilateral nasal polyps] |
| Q54522987 | [Diversity of nasal polyps in microarray technology research]. |
| Q96020832 | [Dynamic monitoring of patients with chronic rhinosinusitis with nasal polyps] |
| Q83802802 | [Effect of TNF-alpha and MMP-9 in the infiltration of eosinophil granulocyte in nasal polyps] |
| Q80394546 | [Effect of endoscopic sinus surgery on asthmatic patients with chronic sinusitis and nasal polyps] |
| Q92851373 | [Effect of endoscopic sinus surgery on olfactory function in patients with chronic rhinosinusitis with nasal polyps] |
| Q73440059 | [Effect of erythromycin on apoptosis of eosinophils in nasal polyps in vitro] |
| Q79817144 | [Effect of erythromycin on the expression of apoptotic gene on eosinophils in nasal polyps in vitro] |
| Q81659423 | [Effect of intranasal glucosteroid on the gene expression of interleukin-5 in nasal polyps] |
| Q79926023 | [Effect of myofibroblast accumulation on the formation and development of nasal polyps] |
| Q88725383 | [Effect of salvianolic acid B on proliferation and apoptosis of human nasal polyps fibroblasts] |
| Q53657834 | [Effect on the recovery process of nasal sinus mucosa with nasosinusitis and nasal polyps influenced by applying Chinese herbal preparation]. |
| Q95540098 | [Effects of Baidanhuang lavage fluid nasal irrigation on the postoperative patients with chronic rhinosinusitis with nasal polyps] |
| Q84063125 | [Effects of corticosteroid on Eotaxin and Eotaxin-2 in nasal polyps] |
| Q80553578 | [Effects of dexamethasone on mucin gene expression in human nasal polyps] |
| Q73439931 | [Effects of intranasal budesonide on the infiltration and activation of eosinophils in nasal polyps] |
| Q81409587 | [Effects of intranasal cortocosteroidson on the expression of Aquaporin-5 in human nasal polyps] |
| Q88806938 | [Effects of nasal polyps and allergy rhinitis on quantitative evaluation of subjective and objective assessment of chronic rhinosinusitis] |
| Q80168681 | [Effects of systemic corticosteroids on expression of Eotaxin in nasal polyps] |
| Q82237100 | [Effects of toll-like-receptor-9 expression in chronic rhinosinusitis with nasal polyps] |
| Q70431390 | [Electron microscopic observations on lymphatic capillaries of nasal polyps (author's transl)] |
| Q90773900 | [Endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps under the guidance of precision medicine：present state and prospective] |
| Q73015861 | [Endoscopic sinus surgery for recurrent sinusitis and nasal polyps] |
| Q95552002 | [Eosinophilic and non-eosinophilic nasal polyps] |
| Q71963782 | [Eosinophils in nasal mucosa of patients with nasal polyps: preliminary histochemical study] |
| Q81451150 | [Epithelial cell proliferation in nasal polyps] |
| Q80168687 | [Erythromycin effects on apoptosis of epithelial cell in nasal polyps] |
| Q50753211 | [Estradiol receptors expression in nasal polyps and its significance] |
| Q70669889 | [Etiological diagnosis of nasal polyps] |
| Q79413873 | [Etiology of nasal polyps: an update] |
| Q71126267 | [Etiopathogenesis of nasal polyps: are the polyps of allergic origin?] |
| Q81718557 | [European position paper on rhinosinusitis and nasal polyps group] |
| Q81842845 | [Examination expression of CD3 and CD69 in nasal polyps] |
| Q96946702 | [Expression and cellular provenance of interleukin 17A in non-eosinophilic chronic rhinosinusitis with nasal polyps] |
| Q73426350 | [Expression and distribution of Aquaporin 1 in the nasal polyps] |
| Q75333418 | [Expression and distribution of aquaporin-2 in nasal polyps] |
| Q81817449 | [Expression and distribution of aquaporin-5 in human nasal polyps] |
| Q83230843 | [Expression and its significance of aquaporin 5 in nasal polyps with or without allergic rhinitis] |
| Q90773975 | [Expression and mechanism of mast cell activating molecules and their antibodies in allergic rhinitis and nasal polyps] |
| Q99348214 | [Expression and pathological role of galectin-10 in different types of nasal polyps] |
| Q95521535 | [Expression and role of IL-33 and its receptor ST2 in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps] |
| Q78832243 | [Expression and significance of TGF-beta 1 in nasal polyps] |
| Q80016932 | [Expression and significance of interleukin-17 and its receptor in nasal polyps] |
| Q73426454 | [Expression and significance of interleukin-6,8 in human nasal polyps] |
| Q88724395 | [Expression and significance of polymeric immunoglobulin receptor in nasal polyps] |
| Q73590149 | [Expression and significance of vascular permeability factor (VPF) in inflammatory cells of nasal polyps] |
| Q78832519 | [Expression and the role of vascular endothelial growth factor mRNA in nasal polyps] |
| Q80606778 | [Expression difference of toll-like receptors among chronic rhinosinusitis and nasal polyps] |
| Q79770627 | [Expression of NO and NOS in nasal polyps] |
| Q54770932 | [Expression of P-selectin in nasal polyps and its mechanisms]. |
| Q95603016 | [Expression of PPAR-γ in patients with chronic rhinosinusitis without or with nasal polyps] |
| Q82764445 | [Expression of STAT6 in human nasal polyps and the relation between STAT6 and eosinophil infiltration] |
| Q78832231 | [Expression of TNF alpha and VCAM-1 in nasal polyps and relation with eosinophil infiltration] |
| Q78832428 | [Expression of Th1, Th2-typed cytokines and its significance in nasal polyps] |
| Q91647210 | [Expression of amphiregulin in different types of nasal polyps and its correlation with tissue remodeling] |
| Q81055760 | [Expression of aquaporin-1 and Bcl-2 mRNA in eosinophils of the nasal polyps and its significance] |
| Q73440124 | [Expression of cell proliferation and apoptosis gene associated protein on nasal polyps and its significance] |
| Q89097083 | [Expression of heme oxygenase-1 in nasal polyps and regulation by glucocorticoid] |
| Q54635902 | [Expression of hypoxia-inducible factor-1alpha in nasal polyps and its correlation with vascular endothelial growth factor and inducible nitric oxide synthase]. |
| Q92604053 | [Expression of immunological and inflammatory biomarkers in chronic rhinosinusitis with nasal polyps and its predictive value for recurrence] |
| Q77895932 | [Expression of intercellular adhesion molecules in nasal polyps tissue and its significance] |
| Q81335600 | [Expression of monocyte chemotactic protein 1 and vascular endothelial growth factor in nasal polyps] |
| Q80553581 | [Expression of nitric oxide synthase and its significance in nasal polyps] |
| Q85306497 | [Expression of palate, lung, and nasal epithelial clone in primary and recurrent nasal polyps] |
| Q81161440 | [Expression of prolactin in macrophage of nasal polyps and its significance] |
| Q73447079 | [Expression of tenascin and fibronectin in nasal polyps] |
| Q83972285 | [Expression of toll-like receptors signaling pathway in chronic rhinosinusitis with nasal polyps] |
| Q79332392 | [Expression of transforming growth factor beta receptor I and II in chronic rhinosinusitis, nasal polyps and normal nasal mucosa tissues] |
| Q84900857 | [Expressions of EOS and COX-2 in nasal polyps in patients with aspirin triad syndrome and its significance] |
| Q85894779 | [Expressions of IL-13 and IL-13Rα2 in eosinophilic chronic rhinosinusitis with nasal polyps and clinical implications] |
| Q73804381 | [Expressions of chloride channel ClC-2 and ClC-3 in human nasal polyps] |
| Q82492422 | [Expressions of cystic fibrosis transmembrane conductance regulator in epithelial cells of nasal polyps and normal turbinate mucosae] |
| Q80452417 | [Expressions of immunoglobulin E, interleukin-5 and granulocyte-macrophage colony-stimulation factor in nasal polyps tissue] |
| Q70396202 | [Factors inhibiting ciliary movement in the serum of patients with nasal polyps] |
| Q75276631 | [Factors that affect the improvement of olfactory function after endoscopic sinus surgery in patients suffering from chronic sinusitis and/or nasal polyps] |
| Q53715168 | [From the history of the treatment of nasal polyps] |
| Q51571573 | [Gene expression profiles in human nasal polyps studied by DNA microarray]. |
| Q81457482 | [Genetic epidemiologic study on nasal polyps] |
| Q72903641 | [Good results of endoscopic paranasal sinus surgery for chronic or recurrent sinusitis and for nasal polyps] |
| Q70508454 | [Hereditary component in the etiology of nasal polyps] |
| Q68402295 | [Histochemical studies of nasal polyps] |
| Q74414260 | [Histochemical study of nasal polyps] |
| Q72159020 | [Histochemical study of polysaccharides in the mucous membrane of the respiratory portion of the nasal cavity and nasal polyps] |
| Q72792049 | [Histoclinical aspects of nasal polyps] |
| Q71770611 | [Histological and immunohistochemical study of nasal polyps] |
| Q70596209 | [Histological changes in nasal polyps after a single exposure to ultrasound] |
| Q68071355 | [Histomorphological changes in nasal polyps in patients with glucose metabolism disorders] |
| Q73440222 | [Hypoxia effects on vascular endothelial growth factor derived epithelial cells of nasal polyps] |
| Q81438884 | [Immunohistochemical assessment of molecule Ki67 in nasal polyps tissue] |
| Q80387418 | [Immunohistochemical study of p53 and Ki-67 in inverted papillomas and nasal polyps arising from nasal or paranasal regions] |
| Q72712690 | [Immunohistological study of eosinophilic infiltration of nasal polyps in aspirin-induced asthma] |
| Q57166694 | [Immunology of chronic rhinosinusitis with nasal polyps as a basis for treatment with biologicals] |
| Q57192315 | [Impact of blood eosinophils on clinical effect of endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps] |
| Q30937512 | [Inflammatory cytokine expression in recurrent nasal polyps by antibody chips]. |
| Q91734954 | [Interpretation of 2020 European Position Paper on Rhinosinusitis and Nasal Polyps] |
| Q83943106 | [Investigation of GR mRNA quantu expression in chronic sinusitis and nasal polyps] |
| Q88987145 | [Investigation on the expression of microvessel pericyte coverage index and lymph vessel density in nasal polyps] |
| Q84974879 | [Medical and surgical treatment of nasal polyps in endoscopic era] |
| Q80606822 | [Medical treatment of nasal polyps and its future] |
| Q70396206 | [Microforms of respiratory tract diseases in families with nasal polyps] |
| Q85358930 | [Morphogenesis of the stromal tissue of nasal polyps] |
| Q76125698 | [Multiple nasal polyps and exophthalmia.] |
| Q73334159 | [Nasal polyps and adenoid vegetations] |
| Q71711190 | [Nasal polyps and appearance of basophilic cells on the mucosal surface of nose] |
| Q68893224 | [Nasal polyps and cellular immunity] |
| Q54197579 | [Nasal polyps and chronic sinusitis as a possible adverse effect of non-selective beta blockers] |
| Q69795820 | [Nasal polyps and food intolerance: is there any correlation] |
| Q68799684 | [Nasal polyps and hypersensitivity] |
| Q80342766 | [Nasal polyps and osteolyses] |
| Q71639337 | [Nasal polyps and substance P: a preliminary report] |
| Q95552011 | [Nasal polyps associated with nasopharyngeal carcinoma in child: one case report and review] |
| Q73089072 | [Nasal polyps from a patient's perspective. Good results with drug therapy and surgery] |
| Q52841123 | [Nasal polyps in a chimpanzee]. |
| Q71140539 | [Nasal polyps in children] |
| Q82528524 | [Nasal polyps in ethmoid and sphenoid sinus with oculomotor nerve paralysis: a case report] |
| Q74702052 | [Nasal polyps of olfactory sulcus] |
| Q95411062 | [Nasal polyps, sialolithiasis, oropharyngeal cancer. Otolaryngology: exciting like a thriller] |
| Q72113348 | [Nasal polyps: a possible aspects of nasal hyperreactivity] |
| Q71297431 | [Nasal polyps: comparative immunological study of polyps with different histopathologic types] |
| Q71230696 | [Nasotracheal intubation complicated by the avulsion of nasal polyps] |
| Q80831158 | [Observation of maxillary mucosa restoration after the endoscopic sinus surgery operation of chronic sinusitis and nasal polyps] |
| Q82987746 | [Observation of ultrastructure and ECP expression in nasal polyps] |
| Q78832431 | [Observations of the curative effect with various liquid for post operative irrigation of ESS of treating chronic sinusitis and nasal polyps] |
| Q73485896 | [Observations on hemorrhagic nasal polyps] |
| Q74522472 | [Obstructive sleep apnea and obstructing nasal polyps] |
| Q88806047 | [Orbital decompression for intraorbital hematoma after surgery of recurrent nasal polyps: a case report] |
| Q82197482 | [Pathological and ultrastructural observation on the epithelia of nasal cavity and nasal sinuses in chronic sinusitis and nasal polyps after endoscopic sinus surgery] |
| Q95451082 | [Phenotypes of chronic rhinosinusitis with nasal polyps: the progresses in precision medicine] |
| Q89318751 | [Precision medicine in patients with chronic rhinosinusitis with nasal polyps] |
| Q93214792 | [Predictive study on recurrence of chronic sinusitis with nasal polyps by tissue eosinophils and sinus CT] |
| Q77417250 | [Preliminary assessment of the role of IL-5 in the pathogenesis of nasal polyps] |
| Q83558362 | [Preliminary clinical investigation of coblation-assisted functional endoscopic sinus surgery for chronic sinusitis and nasal polyps] |
| Q68121620 | [Prevention of recurrence of nasal polyps after surgical intervention: effectiveness of topical corticosteroid preparations] |
| Q53861733 | [Primary study of Na+ channels in the epithelial cells of nasal polyps and of the effect of IL-1 beta on Na+ channels] |
| Q71063756 | [Problems with nasal polyps] |
| Q89005569 | [Progress of monoclonal antibody treatment for chronic rhinosinusitis with or without nasal polyps] |
| Q79452633 | [Quality of life survey on patients with chronic rhinosinusitis and nasal polyps] |
| Q85830989 | [Quantitative analysis of interleukin-5 mRNA and protein in nasal polyps] |
| Q80096190 | [RANTES expression in nasal polyps fibroblasts; spontaneously and after stimulation with lipopolisaccharides (LPS) and phytohemagglutinin (PHA)] |
| Q81842818 | [Relationship between allergic factors and chronic sinusitis with or without nasal polyps] |
| Q68058527 | [Relationships between nasal polyps and nasal allergy] |
| Q69480109 | [Research on the etiology of nasal polyps] |
| Q78875804 | [Revision endoscopic sinus surgery for recurrent nasal polyps] |
| Q80553576 | [Role of ICAM-1 in eosinophilia and prognosis of nasal polyps] |
| Q68784590 | [Role of adrenocortical insufficiency in the etiology of nasal polyps] |
| Q70620353 | [Role of food hypersensitivity in the etiology of nasal polyps] |
| Q68044029 | [Role of mast cells in the etiopathogenesis of nasal polyps] |
| Q73426353 | [Roles of CD43, CD20 and local IgE in the pathogenesis of nasal polyps] |
| Q83836966 | [Secretion and expression of E-selectin in nasal polyps] |
| Q85618570 | [Serum allergen-specific IgE in patients with eosinophilic nasal polyps] |
| Q81400903 | [Serum levels and clinical values of soluble intercellular adhesion molecule-1 in patients with nasal polyps] |
| Q80154077 | [Severe complications in the treatment of chronic rhinosinusitis and nasal polyps with endoscopic sinus surgery] |
| Q73439985 | [Significance and detection of interleukin-8 in human nasal polyps] |
| Q82351220 | [Sino nasal polyps: true and false tumors] |
| Q77361832 | [Steroid therapy and surgical treatment of nasal polyps: cytological analysis] |
| Q92604042 | [Strengthening the precision medicine of chronic rhinosinusitis with nasal polyps in clinical practice] |
| Q70716371 | [Structural study of nasal polyps] |
| Q84802809 | [Study of phosphorylated ERK1/2 on nasal polyps] |
| Q73171195 | [Study on endoscopic sinus surgery management of chronic sinusitis with nasal polyps] |
| Q88725408 | [Study on the mutation of Filaggrin gene in nasal polyps] |
| Q92604077 | [Study on the relationship between 11β-hydroxysteroid dehydrogenase and glucocorticoid response in nasal polyps] |
| Q88807099 | [Surgical treatment of cronic rhinosinusitis with nasal polyps] |
| Q84838495 | [Taste perception in patients with chronic rhinosinusitis with nasal polyps treated with oral glucocorticosteroid therapy] |
| Q80553602 | [The T-lymphocytes subsets expression in the human recurrent nasal polyps] |
| Q88807811 | [The analysis of the allergic rhinitis and chronic rhinosinusitis with nasal polyps] |
| Q86340168 | [The clinical relationship between allergic rhinitis and allergic factors and chronic rhinosinusitis with or without nasal polyps] |
| Q80161174 | [The concentration and expression of IL-4, IL-5, IL-6, IL-8 in human nasal polyps tissues] |
| Q64124370 | [The correlation between the types of the uncinate process superiorattachment and chronic frontal sinusitis without nasal polyps] |
| Q86051373 | [The correlation study of allergic rhinitis and chronic rhinosinusitis with nasal polyps in Ningxia region] |
| Q91938336 | [The correlation study on pathogenesis of B cell activation factor in eosinophils and neutrophil- predominant chronic rhinosinusitis with nasal polyps] |
| Q84433372 | [The dependence of Toll-receptor expression on pathomorphological features of nasal polyps in patients with polypous rhinosinusitis] |
| Q80661420 | [The difference in some clinical and pathological characteristics between chronic sinusitis patients with and without nasal polyps] |
| Q91162108 | [The early therapeutic effect of low-dose clarithromycin for chronic nasosinusitis with nasal polyps] |
| Q83510970 | [The effect of VEGF and MVD in the formation of nasal polyps] |
| Q82629362 | [The effect of fungi in the pathogenesis of nasal polyps and chronic rhinosinusitis] |
| Q82728585 | [The effect of the expression and influence of MMP-9 on prognosis of nasal polyps] |
| Q84452393 | [The efficacy and safety of a short course of budesonide inhalation suspension via transnasal nebulization in chronic rhinosinusitis with nasal polyps] |
| Q85914941 | [The efficacy and safety of budesonide inhalation suspension via transnasal nebulization compared with oral corticosteroids in chronic rhinosinusitis with nasal polyps] |
| Q90451757 | [The efficacy of omalizumab in the treatment of chronic rhinosinusitis with nasal polyps: a discussion of 2 refractory cases] |
| Q95466604 | [The expression and clinical significance of hyaluronan synthase in nasal polyps] |
| Q84320294 | [The expression and correlation of inducible nitric oxide synthase, Bax and Bcl-2 in nasal polyps] |
| Q95451107 | [The expression and role of MIF, NF-κB and IL-1β in nasal polyps] |
| Q88997793 | [The expression and role of PLUNC, TLR2 and NF-κB in nasal polyps] |
| Q81121469 | [The expression and significance of Fas/FasL in nasal polyps tissue] |
| Q83817917 | [The expression and significance of interleukin-17 and the infiltrating eosinophils in nasal polyps and nasal mucous of allergic rhinitis] |
| Q88806859 | [The expression of IL-22 in nasal polyps tissues] |
| Q95427543 | [The expression of IL-9, IL-17 and Foxp3 in nasal polyps] |
| Q84312577 | [The expression of interleukin-17 in blood and nasal tissue of patients with allergic rhinltis and nasal polyps] |
| Q95603013 | [The expression of interleukin-25 in blood and nasal tissue of patients with chronic rhinosinusitis with nasal polyps] |
| Q82764456 | [The expression of mucins gene in the human nasal polyps and allergic rhinitis] |
| Q78875898 | [The expression of transforming growth factor alpha and its receptor in nasal polyps] |
| Q103767823 | [The impact of endoscopic sinus surgery on sinonasal microbiome of chronic rhinosinusitis with nasal polyps] |
| Q88806074 | [The impacts of endoscopic sinus surgery with middle turbinate and superior turbinate resection on quality of life and olfactory function in patients with chronic rhinosinusitis with nasal polyps] |
| Q78832364 | [The infiltration and activation stage of eosinophils in nasal polyps] |
| Q88806086 | [The inflammatory pattern and the characteristics of mucous remodeling in different immune type of nasal polyps] |
| Q80831061 | [The influence of protein kinase C inhibitor in eosinophil apoptosis of nasal polyps] |
| Q84404633 | [The influence of the systemic glucocorticosteroid therapy and intranasal surgery on the taste and smell senses in patients with nasal polyps] |
| Q88997959 | [The microbiology of chronic rhinosinusitis with nasal polyps in different phenotype of peripheral blood eosinophils] |
| Q88997622 | [The new therapy progress of recurrent nasal polyps] |
| Q89272505 | [The progress study of tumor suppressor gene and apoptosis gene in nasal polyps] |
| Q81400906 | [The protein expression difference of transforming growth factor beta1, matrix metalloproteinases 1,7,9 and tissue inhibitors of matrix metalloproteinases-1 between chronic rhinosinusitis, nasal polyps and normal mucosa tissues] |
| Q80553573 | [The regulation of PKCalpha in eosinophil infiltration and proliferation in nasal polyps] |
| Q73909337 | [The relation between nasal polyps and allergy of the respiratory tract] |
| Q85306542 | [The relationship of the expression of thymic stromal lymphopoietin in nasal polyps tissues and Th2 inflammatory response] |
| Q81811762 | [The role of CD137 in the growth of nasal polyps] |
| Q58566274 | [The role of MAPK signaling pathway in the repair of mucosal epithelium in chronic sinusitis with nasal polyps and without nasal polyps] |
| Q88997642 | [The role of PACAP protein in chronic sinusitis with or without nasal polyps] |
| Q91162061 | [The role of Smad signaling pathway in the repair of mucosal epithelium in chronic sinusitis with nasal polyps and without nasal polyps] |
| Q98722769 | [The role of budesonide on CD8⁺CD25⁺Foxp3⁺ Treg cells in neutrophilic nasal polyps] |
| Q73354685 | [The role of chemokines in nasal polyps] |
| Q81634617 | [The role of chosen cytokines in etiology of nasal polyps] |
| Q103767759 | [The role of epithelial cells in the formation and development of nasal polyps] |
| Q95427538 | [The role of interleukin-2 pathway in pathogenesis of nasal polyps] |
| Q88680883 | [The role of type 2 innate lymphoid cells in the pathogenesis of eosinophilic chronic rhinosinusitis with nasal polyps] |
| Q73439986 | [The secretion of chemokine RANTES in epithelial cells of nasal polyps and its significance] |
| Q73433209 | [The significance of matrix metalloproteinases expression in nasal polyps] |
| Q82197455 | [The significance of microvessel density and CD34 expression in nasal polyps] |
| Q85641532 | [The standardized perioperative treatment of chronic rhinosinusitis with nasal polyps and asthma] |
| Q92604071 | [The value of sinus computed tomography in predicting the response to oral glucocorticoids in chronic rhinosinusitis with nasal polyps] |
| Q79153920 | [Three cases report of nasal polyps followed kidney transplantation] |
| Q53629702 | [Treatment for intraorbital hematoma by orbital decompression after surgery of recurrent nasal polyps: a case report]. |
| Q70641654 | [Treatment of nasal polyps with ultrasound] |
| Q67885301 | [Ultrastructure of mast cells in nasal polyps] |
| Q83510960 | [Up-regulation of Wnt5A in chronic rhinosinusitis with nasal polyps] |
| Q75951737 | [Value of histologic examination of nasal polyps in diagnosis of allergy.] |
| Q88806191 | [Value research of chemokines in eosinophilic chronic rhinosinusitis with nasal polyps] |
| Q80016938 | [Vascular cell adhesion molecule-1, eotaxin and vascular endothelial growth factor in nasal polyps after endoscopic surgery] |
| Q97092160 | miR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition by Targeting CDK6 in Nasal Polyps |
| Q61851658 | p53 over-expression and its correlation with PCNA index in nasal polyps |
| Q91268394 | γδT cells contribute to type 2 inflammatory profiles in eosinophilic chronic rhinosinusitis with nasal polyps |
| Q28208887 | mometasone | medical condition treated | P2175 |
| Q11821754 | antrochoanal polyp | subclass of | P279 |
| Q111451677 | human nasal polyp mast cell | anatomical location | P927 |
| Category:Nasal polyp | wikimedia | |
| Arabic (ar / Q13955) | سليلة أنفية | wikipedia |
| Catalan (ca / Q7026) | Pòlip nasal | wikipedia |
| Nasenpolyp | wikipedia | |
| Nasal polyp | wikipedia | |
| Poliposis nasal | wikipedia | |
| Persian (fa / Q9168) | پولیپ بینی | wikipedia |
| Polypose nasosinusienne | wikipedia | |
| פוליפ באף | wikipedia | |
| Քթի պոլիպ | wikipedia | |
| Polip hidung | wikipedia | |
| Poliposi nasosinusale | wikipedia | |
| 鼻茸 | wikipedia | |
| 비용종 | wikipedia | |
| nb | Nasalpolypp | wikipedia |
| Neuspoliepen | wikipedia | |
| or | ନାକ ପଲିପ୍ | wikipedia |
| Polipy nosa | wikipedia | |
| Pólipo nasal | wikipedia | |
| Полип носа | wikipedia | |
| Nosni polip | wikipedia | |
| ติ่งเนื้อเมือกจมูก | wikipedia | |
| Tatar language (tt / Q25285) | Борын полипы | wikipedia |
| Поліп носа | wikipedia | |
| Polyp mũi | wikipedia | |
| 鼻息肉 | wikipedia |
Search more.